[{"title": "C-Suite: Amgen's CEO Kevin Sharer - Jul. 9, 2009", "desc": null, "date": "09/07/2009", "link": "news.google.com/articles/CBMigwFodHRwczovL21vbmV5LmNubi5jb20vMjAwOS8wNy8wOC9uZXdzL2NvbXBhbmllcy9hbWdlbl9rZXZpbl9zaGFyZXJfYmlvdGVjaF9waGFybWFjZXV0aWNhbHMuZm9ydHVuZS9pbmRleC5odG0_cG9zdHZlcnNpb249MjAwOTA3MDkxMtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5TV1pCV2xKV1ozRnhaRTlLVFJEOUFSakhBU2dCTWdZcEZaeXVrUW8=-w200-h112-p-df", "media": "money.cnn.com", "site": null, "reporter": "Geoffrey Colvin", "sentiment": "negative"}, {"title": "Amgen Down As Cuomo Alleges Massive Corruption, Kickbacks, And Fraud", "desc": null, "date": "30/10/2009", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vYW5kcmV3LWN1b21vLWdvZXMtYWZ0ZXItYW1nZW4tZm9yLWtpY2tiYWNrLXNjaGVtZS0yMDA5LTEw0gFdaHR0cHM6Ly93d3cuYnVzaW5lc3NpbnNpZGVyLmNvbS9hbmRyZXctY3VvbW8tZ29lcy1hZnRlci1hbWdlbi1mb3Ita2lja2JhY2stc2NoZW1lLTIwMDktMTA_YW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZURnBYZVVweWFFaDRRWFZxVFJEQ0FSaURBaWdCTWdhTmtwU0pPUWM=-w200-h112-p-df", "media": "Business Insider", "site": null, "reporter": "Lawrence Delevingne", "sentiment": "negative"}, {"title": "MedGenesis, Biovail to work on Parkinson's treatment", "desc": null, "date": "12/01/2010", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmN0dm5ld3MuY2EvbW9iaWxlL21lZGdlbmVzaXMtYmlvdmFpbC10by13b3JrLW9uLXBhcmtpbnNvbi1zLXRyZWF0bWVudC0xLjQ3MzA2Nz9jYWNoZT1waXFuZHF2a2g_Y2xpcElkPTM3NTc1NtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUtlRVpIVUcxeFFtNUNMVmR6VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "CTV News", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Top 10 Health Care ETFs", "desc": null, "date": "27/10/2011", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2V0ZnMvdG9wLTEwLWhlYWx0aC1jYXJlLWV0ZnMtMTEyOTEyMzDSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVhhalZtYjFCc1lYZDVaeTAzVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen and FDA Agree to Modify Nplate\u00ae (Romiplostim) Risk Evaluation and Mitigation Strategy", "desc": null, "date": "06/12/2011", "link": "news.google.com/articles/CBMiggFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL3BoYXJtYS9hbWdlbi1hbmQtZmRhLWFncmVlLXRvLW1vZGlmeS1ucGxhdGUlQzIlQUUtcm9taXBsb3N0aW0tcmlzay1ldmFsdWF0aW9uLWFuZC1taXRpZ2F0aW9uLXN0cmF0ZWd50gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJlV3hyVWxCeVNVaFpia0pNVFJDb0FSaXNBaWdCTWdZVmc1S01OUWM=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "5 Amgen Execs Plead the Fifth on Alleged Kickbacks Described in Spreadsheet", "desc": null, "date": "02/03/2011", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmNic25ld3MuY29tL25ld3MvNS1hbWdlbi1leGVjcy1wbGVhZC10aGUtZmlmdGgtb24tYWxsZWdlZC1raWNrYmFja3MtZGVzY3JpYmVkLWluLXNwcmVhZHNoZWV0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUNiVGQwYm10cVZITmZTVkl3VFJDVkFoaTJBU2dCTWdtUk1vcEluV2g3VHdF=-w200-h112-p-df", "media": "CBS News", "site": null, "reporter": "Jim Edwards", "sentiment": "negative"}, {"title": "Morning Market Roundup (12/16/2011)", "desc": null, "date": "16/12/2011", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vMjQ3d2FsbHN0LmNvbS9pbnZlc3RpbmcvMjAxMS8xMi8xNi9tb3JuaW5nLW1hcmtldC1yb3VuZHVwLTEyMTYyMDExL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVXR2g1YlhaNGVYQXlabWc1VFJDcUFSamNBU2dCTWdB=-w200-h112-p-df", "media": "24/7 Wall St.", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Q4 earnings dip 8.5%, bids $1.16 bln for Micromet", "desc": null, "date": "27/01/2012", "link": "news.google.com/articles/CBMid2h0dHBzOi8vd3d3LnByb2FjdGl2ZWludmVzdG9ycy5jby51ay9jb21wYW5pZXMvbmV3cy84MzE5MS9hbWdlbi1xNC1lYXJuaW5ncy1kaXAtODUtYmlkcy0xMTYtYmxuLWZvci1taWNyb21ldC0yNDEwNi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVFVMmxMWDJaNFdrcGlaSFpQVFJDWkFSaktBaWdCTWdB=-w200-h112-p-df", "media": "Proactive Investors UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen shutting down Epogen manufacturing in Longmont", "desc": null, "date": "08/08/2012", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vd3d3LnRpbWVzY2FsbC5jb20vY2lfMjEyNjY0MjEvYW1nZW4tc2h1dHRpbmctZG93bi1lcG9nZW4tbWFudWZhY3R1cmluZy1sb25nbW9udC_SAV5odHRwczovL3d3dy50aW1lc2NhbGwuY29tLzIwMTIvMDgvMDgvYW1nZW4tc2h1dHRpbmctZG93bi1lcG9nZW4tbWFudWZhY3R1cmluZy1pbi1sb25nbW9udC9hbXAv?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNU1SVnA0VlhCNGVUVndhMjFmVFJDakFSaTBBaWdCTWdzQk1JWk1JQ2NXTW1tb2tn=-w200-h112-p-df", "media": "Longmont Times-Call", "site": null, "reporter": "Tony J. Kindelspire", "sentiment": "negative"}, {"title": "Pharma News: Vivus, Inc. (VVUS)'s Contract, Arena Pharmaceuticals, Inc. (ARNA) & Amgen, Inc. (AMGN)'s Financial ...", "desc": null, "date": "05/08/2013", "link": "news.google.com/articles/CBMikAFodHRwczovL3d3dy5pbnNpZGVybW9ua2V5LmNvbS9ibG9nL3BoYXJtYS1uZXdzLXZpdnVzLWluYy12dnVzcy1jb250cmFjdC1hcmVuYS1waGFybWFjZXV0aWNhbHMtaW5jLWFybmEtYW1nZW4taW5jLWFtZ25zLWZpbmFuY2lhbC1yZXN1bHRzLTIxNjEzNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdNR1pJUVRadmVqSkxVR294VFJDYkFSakVBaWdCTWdhUms0cHF2UVU=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Top 10 Financial Tweets For Monday, August 26 - D.R. Horton (NYSE:DHI), Amgen (NASDAQ:AMGN)", "desc": null, "date": "26/08/2013", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzM4NjQ5MDXSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVBWQzFtWmxOUVpGQnljVFpLVFJETEFSajVBU2dCTWdPQk1oWQ=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Shopping on the Nasdaq", "desc": null, "date": "13/09/2013", "link": "news.google.com/articles/CBMiM2h0dHBzOi8vcHJvLnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL3Nob3BwaW5nLW5hc2RhcdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNU5NV2gzV0dnMmRUZFdkWGc0VFJEQ0FSaURBaWdCTWdB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ed Ponsi", "sentiment": "negative"}, {"title": "NPS Pharmaceuticals Incurs Wider Q3 Loss, Revenues Miss", "desc": null, "date": "11/11/2014", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL25wcy1waGFybWFjZXV0aWNhbHMtaW5jdXJzLXdpZGVyLXEzLTE1NTAwMjc3OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWxia1JOVjFJMFVHdDJZemN3VFJDZkFSaTlBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Affymax, once a promising biotech, is dissolving", "desc": null, "date": "24/06/2014", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FmZnltYXgtb25jZS1hLXByb21pc2luZy1iaW90ZWNoLWRpc3NvbHZpbmfSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlOMGRxWlVOaFowczBSM2MyVFJEUUFSaUFBU2dCTWdhTmhJekhQUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan", "desc": null, "date": "26/11/2014", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYWxleGlvbnMtYWx4bi1zb2xpcmlzLWdldHMtb3JwaGFuLTIxMTAwMjE5MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNU5WWGg1VFdOMGVsSlNXRTFIVFJDb0FSaXNBaWdCTWdrQlFKS1dwT2JBUndJ=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "US stocks and sectors to watch after NY Ebola case", "desc": null, "date": "24/10/2014", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3VzLXN0b2Nrcy1zZWN0b3JzLXdhdGNoLW55LTA4NDU0MTExNy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZTRVZXUVZKUmEwTkdla1ZEVFJDaUFSaTJBaWdCTWdZRkVKakZqZ3M=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": "Holly Ellyatt", "sentiment": "negative"}, {"title": "Amgen's Humira copy succeeds in skin disease trial", "desc": null, "date": "08/10/2014", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL25ld3MvYW1nZW5zLWh1bWlyYS1jb3B5LXN1Y2NlZWRzLXNraW4tZGlzZWFzZS10cmlhbC0xNjE1MzQwNDEtLWZpbmFuY2UuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFMWFpoWkd4UlZHY3dNak4zVFJDb0FSaXNBaWdCTWdZTmFaS21xZ2M=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's Repatha scores an exclusive with CVS", "desc": null, "date": "23/11/2015", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLXMtcmVwYXRoYS1zY29yZXMtYW4tZXhjbHVzaXZlLWN2c9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXhSWFJIWVRWTmVVaGFSbWhuVFJDVUFSajZBU2dCTWdrTmNvYW5yYVpNOWdB=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Amgen To Acquire Privately-Held Dezima Pharma", "desc": null, "date": "16/09/2015", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tYWNxdWlyZS1wcml2YXRlbHktaGVsZC1kZXppbWEtcGhhcm1hLTMwMDE0NDA0Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTZkbEZKYmxwaWVqSlVUMGx4VFJDUUFSamVBaWdCTWdNQllBNA=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Massive South S.F. biotech project from developer HCP breaks ground - San Francisco Business Times", "desc": null, "date": "04/02/2015", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vYmxvZy9iaW90ZWNoLzIwMTUvMDIvaGNwLWNvdmUtYXQtb3lzdGVyLXBvaW50LWJtci1hbWduLXRtby1jYWxpY28uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJNbHBSTUVOMU1IYzFZVFpzVFJDb0FSaXNBaWdCTWdZQlVZcU1NUVU=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Is This a Biotech Bubble?", "desc": null, "date": "27/03/2015", "link": "news.google.com/articles/CBMiPWh0dHBzOi8vbW9uZXltb3JuaW5nLmNvbS8yMDE1LzAzLzI3L2lzLXRoaXMtYS1iaW90ZWNoLWJ1YmJsZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNOVFptYWpoUk0yaHVXWHBWVFJESEFSajlBU2dCTWdZRkVZNG1KZ1k=-w200-h112-p-df", "media": "Money Morning", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Medicines Company Announces Phase-1 Data on MDCO-216", "desc": null, "date": "17/12/2015", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvbWVkaWNpbmVzLWNvbXBhbnktYW5ub3VuY2VzLXBoYXNlLTEtMTMwNjExNTQ5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNURYMGRqWW1oeU4yMXNjMWRRVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Will Amgen Earnings Shape Biotech for the Rest of 2015?", "desc": null, "date": "21/04/2015", "link": "news.google.com/articles/CBMibmh0dHBzOi8vMjQ3d2FsbHN0LmNvbS9oZWFsdGgtYW5kLWhlYWx0aGNhcmUvMjAxNS8wNC8yMS93aWxsLWFtZ2VuLWVhcm5pbmdzLXNoYXBlLWJpb3RlY2gtZm9yLXRoZS1yZXN0LW9mLTIwMTUv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTZUMk5vV1c1dFZuTnFNRzVNVFJDNEFSaVNBaWdCTWdB=-w200-h112-p-df", "media": "24/7 Wall St.", "site": null, "reporter": "Paul Ausick", "sentiment": "negative"}, {"title": "Amgen launches delivery device for automatic administration of its blockbuster Neulasta", "desc": null, "date": "04/03/2015", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vci1kL2FtZ2VuLWxhdW5jaGVzLWRlbGl2ZXJ5LWRldmljZS1mb3ItYXV0b21hdGljLWFkbWluaXN0cmF0aW9uLW9mLWl0cy1ibG9ja2J1c3Rlci1uZXVsYXN0YdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9SSE5EVGpReFpHaG1NbEJ5VFJENEFSaklBU2dCTWdZbFpJcU5OUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "U.K. cost gatekeeper says 'no' to Amgen's PCSK9 cholesterol fighter Repatha", "desc": null, "date": "18/11/2015", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcmVndWxhdG9yeS91LWstY29zdC1nYXRla2VlcGVyLXNheXMtbm8tdG8tYW1nZW4tcy1wY3NrOS1jaG9sZXN0ZXJvbC1maWdodGVyLXJlcGF0aGHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXhSWFJIWVRWTmVVaGFSbWhuVFJDVUFSajZBU2dCTWdrTmNvYW5yYVpNOWdB=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Announces Launch Of New Neulasta\u00ae (Pegfilgrastim) Delivery Kit", "desc": null, "date": "03/03/2015", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLWFubm91bmNlcy1sYXVuY2gtb2YtbmV3LW5ldWxhc3RhJUMyJUFFLXBlZ2ZpbGdyYXN0aW0tZGVsaXZlcnkta2l00gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1NRGd6Ukc5eGFXbExkRXhUVFJENkFSakpBU2dCTWdZbFpJcU5PUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Celgene's next-gen psoriasis drug dissed by German cost watchdog", "desc": null, "date": "22/05/2015", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2NlbGdlbmUtcy1uZXh0LWdlbi1wc29yaWFzaXMtZHJ1Zy1kaXNzZWQtYnktZ2VybWFuLWNvc3Qtd2F0Y2hkb2fSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTNlbWxxYW5CNFV6UmpRV05LVFJDb0FSaXNBaWdCTWdrQkFJTGcwcUpNWUFN=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "FDA swats down Pfizer's Xeljanz in plaque psoriasis", "desc": null, "date": "15/10/2015", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcmVndWxhdG9yeS9mZGEtc3dhdHMtZG93bi1wZml6ZXItcy14ZWxqYW56LXBsYXF1ZS1wc29yaWFzaXPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDRiRGhhZURJMVYySklURzkyVFJDbUFoaVdBU2dCTWdhSm80eUhRUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Carly Helfand", "sentiment": "negative"}, {"title": "Biosimilar of Novartis' eye drug Lucentis launched in India", "desc": null, "date": "19/06/2015", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Jpb3NpbWlsYXItb2Ytbm92YXJ0aXMtZXllLWRydWctbHVjZW50aXMtbGF1bmNoZWQtaW5kaWHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZkMWRuTm1oa1Yyd3lTR1V5VFJEaEFSamhBU2dCTWdhbEVvcE5rUXM=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Zarxio, Novartis AG (ADR) (NYSE:NVS) Biosimilar Drug Gets Approved by FDA", "desc": null, "date": "11/03/2015", "link": "news.google.com/articles/CBMiZmh0dHA6Ly9zdG9ja3Mub3JnL2Jpb3BoYXJtYS96YXJ4aW8tbm92YXJ0aXMtYWctYWRyLW55c2VudnMtYmlvc2ltaWxhci1kcnVnLWdldHMtYXBwcm92ZWQtYnktZmRhLzI5MTA5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHRkblJMYkdOaWEwUXlWalEzVFJDeUFSaWNBaWdCTWdZUlU0RE5JUWM=-w200-h112-p-df", "media": "Stocks.org", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Why Amgen Is the Best S&P 500 Company", "desc": null, "date": "22/03/2016", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vb3Bpbmlvbi93aHktYW1nZW4taXMtdGhlLWJlc3Qtcy1hbXAtcC01MDAtY29tcGFueS0xMzUwMjQ5NNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNW1WVUYxZFRaaGVWZHZOblY0VFJDb0FSaXNBaWdCTWdNQnNBNA=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Rhonda Schaffler", "sentiment": "negative"}, {"title": "Amgen (AMGN) Reports Positive Data on Prolia and Repatha", "desc": null, "date": "30/08/2016", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXJlcG9ydHMtcG9zaXRpdmUtZGF0YS0xNDAzMDIxMjkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdWbGh4VTNZd1RtRlVWM1ZLVFJDWkFSaktBaWdCTWdhaE1wWXdtUWs=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "S&P To 2100? Goldman Weighs In - Amgen (NASDAQ:AMGN)", "desc": null, "date": "12/09/2016", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzg0NDY1MTDSASxodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvODQ0NjUxMA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Wayne Duggan", "sentiment": "negative"}, {"title": "Amgen calls on TV actor 'McDreamy' to lead latest Breakaway from Cancer campaign", "desc": null, "date": "23/05/2016", "link": "news.google.com/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc2FsZXMtYW5kLW1hcmtldGluZy9hbWdlbi1jYWxscy10di1hY3Rvci1tY2RyZWFteS10by1sZWFkLWxhdGVzdC1icmVha2F3YXktZnJvbS1jYW5jZXItY2FtcGFpZ27SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVNkSE5EYlhFMFVVMXpabHBzVFJDb0FSaXNBaWdCTWdZcFZvenRLUWM=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Beth Bulik", "sentiment": "negative"}, {"title": "Amgen strikes $674M cardiovascular RNAi pact with Arrowhead", "desc": null, "date": "29/09/2016", "link": "news.google.com/articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZW1iYXJnby1saWZ0cy03LTMwYW0tZXQtYW1nZW4tc3RyaWtlcy02NzMtNW0tY2FyZGlvdmFzY3VsYXItcm5haS1wYWN0LWFycm93aGVhZNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHlSMlpOUldaeWVIVk1XbGhOVFJDb0FSaXNBaWdCTWdhSmNaQkxPUVk=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Google unit stakes biotech claim with lease of entire Onyx campus - San Francisco Business Times", "desc": null, "date": "18/02/2016", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vYmxvZy9iaW90ZWNoLzIwMTYvMDIvZ29vZ2xlLWFscGhhYmV0LXZlcmlseS1vbnl4LWFtZ2VuLWFtZ24tZ29vZy1jcmUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTRUSFJIZVd3MFUxa3dTeTFKVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Amgen's global footprint grows with Japan a focal point", "desc": null, "date": "31/07/2016", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvYW1nZW4tcy1nbG9iYWwtZm9vdHByaW50LWdyb3dzLWphcGFuLWEtZm9jYWwtcG9pbnTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXBaRFpTV2pKd1VWZzJSWE5UVFJDb0FSaXNBaWdCTWdNQjBRdw=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Regeneron cites success of PhIII anti-NGF pain drug after big rival bails out", "desc": null, "date": "02/05/2016", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3JlZ2VuZXJvbi1hZHZhbmNlcy1pdHMtcGhpaWktYW50aS1uZ2YtcGFpbi1kcnVnLWFmdGVyLWEtYmlnLXJpdmFsLWJhaWxzLW91dNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFRazVmZFhSWVNXNVdjVTlQVFJDb0FSaXNBaWdCTWdhcEE0cXZQUVk=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": "John Carroll", "sentiment": "negative"}, {"title": "Amgen picks up an edge for Repatha in duel with Sanofi and Regeneron", "desc": null, "date": "11/07/2016", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLXBpY2tzLXVwLWVkZ2UtZm9yLXJlcGF0aGEtZHVlbC1zYW5vZmktYW5kLXJlZ2VuZXJvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdSVU0xYkd4RlRWWjNiSFV3VFJDb0FSaXNBaWdCTWdhcFJZcnRKUVk=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Regeneron CEO pushes back on pricing criticism of new gen cholesterol meds", "desc": null, "date": "13/05/2016", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JlZ2VuZXJvbi1jZW8tcHVzaGVzLWJhY2stY3JpdGljaXNtLXByaWNpbmctcGNzazktaW5oaWJpdG9yc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNW1Na1ptY1U1WWRtTnZMVWR4VFJDb0FSaXNBaWdCTWdtaFVvcU5KYWhVTWdF=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Novartis spends on manufacturing, expecting big biosimilar payoff", "desc": null, "date": "20/06/2016", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9ub3ZhcnRpcy1zcGVuZHMtbWFudWZhY3R1cmluZy1leHBlY3RpbmctYmlnLWJpb3NpbWlsYXItcGF5b2Zm0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXphbTgyUlhobmRHeEpiMFpxVFJDb0FSaXNBaWdCTWdZZElJeXluQWs=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Aiming to shield $14B in sales, AbbVie smacks Amgen with a patent suit over Humira biosim", "desc": null, "date": "08/08/2016", "link": "news.google.com/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FpbWluZy10by1zaGllbGQtMTRiLXNhbGVzLWFiYnZpZS1zbWFja3MtYW1nZW4tYS1wYXRlbnQtc3VpdC1vdmVyLWh1bWlyYS1iaW9zaW3SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZjbXRmWDNoeUxYSlFNVEpTVFJDb0FSaXNBaWdCTWdZTlFwcG1vZ2s=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Novartis' Sandoz aims for 5 biosim launches by 2020", "desc": null, "date": "20/06/2016", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25vdmFydGlzLXNhbmRvei1haW1zLWZvci01LWJpb3NpbS1sYXVuY2hlcy1ieS0yMDIw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFWM2h4TkhwV1IwOW9XR1F6VFJDb0FSaXNBaWdCTWdZZElJcXluQWs=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Carly Helfand", "sentiment": "positive"}, {"title": "Most-wanted buyout target Medivation and hostile bidder Sanofi line up for board fight", "desc": null, "date": "02/06/2016", "link": "news.google.com/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL21vc3Qtd2FudGVkLWJ1eW91dC10YXJnZXQtbWVkaXZhdGlvbi1hbmQtaG9zdGlsZS1iaWRkZXItc2Fub2ZpLWxpbmUtdXAtZm9yLWJvYXJkLWZpZ2h00gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUVhbGhFY2pJNFRIWjFZMlJrVFJDb0FSaXNBaWdCTWdZQmtJcU12QVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "CDMO Patheon positions itself for $625M IPO next week", "desc": null, "date": "12/07/2016", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9jZG1vLXBhdGhlb24tcG9zaXRpb25zLWl0c2VsZi1mb3ItNjI1bS1pcG8tbmV4dC13ZWVr0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpXVTFhWVMxdWVGcFlSR3hoVFJDb0FSaXNBaWdCTWdZcGdJeHZ3UVE=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Joseph Keenan", "sentiment": "negative"}, {"title": "UPDATED: Pfizer closing Hospira plant in Colorado, 100 jobs to be lost", "desc": null, "date": "23/06/2016", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9wZml6ZXItY2xvc2luZy1ob3NwaXJhLXBsYW50LWNvbG9yYWRvLTEwMC1qb2JzLXRvLWJlLWxvc3TSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJWVkZwVEhaR2MwcHNOR1JYVFJDb0FSaXNBaWdCTWdhQlk1cU9wUWc=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "positive"}, {"title": "Japan's latest approvals include Praluent in second PCSK9 inhibitor", "desc": null, "date": "05/07/2016", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvamFwYW4tcy1sYXRlc3QtYXBwcm92YWxzLWluY2x1ZGUtcHJhbHVlbnQtc2Vjb25kLXBjc2s5LWluaGliaXRvctIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURiblJPZVVKeVJIQlNkalZoVFJDb0FSaXNBaWdCTWdZSndJaEtTUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AbbVie North Chicago plant has second fire", "desc": null, "date": "16/06/2016", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9hYmJ2aWUtbm9ydGgtY2hpY2Fnby1wbGFudC1oYXMtc2Vjb25kLWZpcmXSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpNVmREYVc5Zk56UlRhazlFVFJDb0FSaXNBaWdCTWdZRkJwd0tsZ2s=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "AstraZeneca to 'reshape' manufacturing as part of $1.5B cost-cutting effort", "desc": null, "date": "02/05/2016", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9hc3RyYXplbmVjYS1haW1zLXRvLXN0cmVhbWxpbmUtbWFudWZhY3R1cmluZ9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDVSek5rZDNCcFVqaG5Ra05RVFJDb0FSaXNBaWdCTWdNQjhBQQ=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Sagonowsky", "sentiment": "negative"}, {"title": "Otezla Captures Psoriasis and Psoriatic Arthritis Market Shares", "desc": null, "date": "14/05/2016", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL290ZXpsYS1jYXB0dXJlcy1wc29yaWFzaXMtcHNvcmlhdGljLWFydGhyaXRpcy0xMzA4MTQzMjguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWlZakJ0V0ZGVmFVZGxWbGRLVFJDeEFSaWNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Unilife releases internal investigation results; finds little financial damage", "desc": null, "date": "25/10/2016", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vZHJ1Zy1kZWxpdmVyeS91bmlsaWZlLXJlbGVhc2VzLWludGVybmFsLWludmVzdGlnYXRpb24tcmVzdWx0cy1maW5kcy1saXR0bGUtZmluYW5jaWFsLWRhbWFnZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFYek5FZWxkS2NFcFFjMHh2VFJDbkFSaXRBaWdCTWdhZG81Uk11UVk=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Joseph Keenan", "sentiment": "negative"}, {"title": "Novartis' Entresto uptake better in EU as U.S. warms slowly to new heart meds", "desc": null, "date": "22/04/2016", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25vdmFydGlzLWVudHJlc3RvLXVwdGFrZS1iZXR0ZXItZXUtYXMtdS1zLXdhcm1zLXNsb3dseS10by1uZXctaGVhcnQtbWVkc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpXVm93ZEdaSk1uSnZiMGxxVFJDb0FSaXNBaWdCTWdZOUE0Z3pFUW8=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "positive"}, {"title": "Six Advanced Studies for Roche's Atezolizumab", "desc": null, "date": "27/03/2016", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3Mvc2l4LWFkdmFuY2VkLXN0dWRpZXMtcm9jaGUtYXRlem9saXp1bWFiLTA1MDQzNDE5Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXdlVzVYV1dnNWFuaFVhWEZGVFJDM0FSaVRBaWdCTWdZcE5aYk9JUWc=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Kite Pharma Q4 Loss Wider but Focus Remains on KTE-C19", "desc": null, "date": "01/03/2016", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3Mva2l0ZS1waGFybWEtcTQtbG9zcy13aWRlci0xNDQwMDI4OTUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhUbU4wVDNOSmNsTnVRemgwVFJDeEFSaWNBaWdCTWdZaEpwTHJIUWc=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "After $1 billion buyout of Flexus, team quickly builds Arcus Biosciences in Hayward - San Francisco Business Times", "desc": null, "date": "27/07/2016", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vYmxvZy9iaW90ZWNoLzIwMTYvMDcvYXJjdXMtZmxleHVzLXRlcnJ5LXJvc2VuLWNhbmNlci1jZWxnLW52cy1ibXktYW1nbi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXhORkJ4YkRsWFdFcGFUM2RGVFJDb0FSaXJBaWdCTWdtRllwTEZwaWhGYmdF=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "positive"}, {"title": "BioMarin's Naglazyme Sales Dipped by 31.3% Last Year", "desc": null, "date": "07/03/2016", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYmlvbWFyaW4tbmFnbGF6eW1lLXNhbGVzLWRpcHBlZC0zMS0xMzA3MTAwNDguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHhMV3RKV1c4NE1FNXpSbTVtVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Big Short's Michael Burry Reveals His New Stock Picks", "desc": null, "date": "30/11/2016", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvdGhlLWJpZy1zaG9ydHMtbWljaGFlbC1idXJyeS1yZXZlYWxzLWhpcy1uZXctc3RvY2stcGlja3MtNDkxNTEyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVljM3BOVVRFeVprRkpOMDl1VFJDb0FSaXNBaWdCTWdNRkVBdw=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen An Undervalued Industry Leader", "desc": null, "date": "21/06/2017", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAxNy8wNi8yMS9hbWdlbi1hbi11bmRlcnZhbHVlZC1pbmR1c3RyeS1sZWFkZXIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHlRME5DWTNSRmVrWXpaV1ZHVFJDTUFSanBBaWdCTWdZQkE0VHJGUTA=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "David Trainer", "sentiment": "negative"}, {"title": "Mapp Enables DMLS To On-Board Over 20 Brands And Deliver Over 700 Million Emails In 18 Months", "desc": null, "date": "14/12/2017", "link": "news.google.com/articles/CBMipgFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9tYXBwLWVuYWJsZXMtZG1scy10by1vbi1ib2FyZC1vdmVyLTIwLWJyYW5kcy1hbmQtZGVsaXZlci1vdmVyLTcwMC1taWxsaW9uLWVtYWlscy1pbi0xOC1tb250aHMtMTAwMTkzOTIyMT9taVJlZGlyZWN0cz0x0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iIkNnNXJURzk2YjI0eVlXb3ljRkUyVFJCdEdKQURLQUV5QUE=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "This Stock Turned $1,000 Into $1.53 Million in Less Than 33 Years", "desc": null, "date": "23/05/2017", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDE3LzA1LzIzL3RoaXMtc3RvY2stdHVybmVkLTEwMDAtaW50by0xNTMtbWlsbGlvbi1pbi1sZXNzLXRoLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtRUzFPYTA4eFozZFZabFYxVFJDM0FSaVRBaWdCTWdZSmRKaXVLUWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Sean Williams", "sentiment": "negative"}, {"title": "Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold - Esperion Therapeutics (NASDAQ:ESPR), Gilead Scien", "desc": null, "date": "23/06/2017", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzk2NDY2NjfSASxodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvOTY0NjY2Nw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Wayne Duggan", "sentiment": "negative"}, {"title": "Pharma CEOs Met With Trump But They Won't Give In to His Demands", "desc": null, "date": "31/01/2017", "link": "news.google.com/articles/CBMiQWh0dHBzOi8vZm9ydHVuZS5jb20vMjAxNy8wMS8zMS90cnVtcC1waGFybWEtY2Vvcy1tZWV0aW5nLWRlbWFuZHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWlaVTFzVUMxTFVWWktURjh6VFJDZkFSaS1BaWdCTWdZQlE1d1FuUWs=-w200-h112-p-df", "media": "Fortune", "site": null, "reporter": "Sy Mukherjee", "sentiment": "negative"}, {"title": "3 ETFs to Watch Out for on Biotech Earnings", "desc": null, "date": "31/07/2017", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvMy1ldGZzLXdhdGNoLWJpb3RlY2gtZWFybmluZ3MtMDQyNjA0NjU4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhjRGd0TlVKMGIzTkNPVU5FVFJDM0FSaVRBaWdCTWdZRklKNWtuQW8=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "SPDR S&P Biotech ETF (XBI): The Quick Guide to XBI", "desc": null, "date": "16/09/2017", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAxNy8wOS9zcGRyLXNwLWJpb3RlY2gtZXRmLXhiaS10aGUtcXVpY2stZ3VpZGUv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWtXSFZwUjBScFIwNDBYMXBoVFJDbUFSaXZBaWdCTWdB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Todd Shriber", "sentiment": "negative"}, {"title": "Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest", "desc": null, "date": "04/12/2017", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL215bGFuLWZkYS1hcHByb3ZhbC1hbWF6b24tYXBvcy0xNDQ2MDI2NzIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUdRbll6TlZWSk5raHpaUzFCVFJDM0FSaVRBaWdCTWdhbE5aanRvUWc=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Cochineal Insects Products: 7 Foods Made With Crushed Bugs", "desc": null, "date": "24/01/2017", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvY29jaGluZWFsLWluc2VjdHMtcHJvZHVjdHMtNy1mb29kcy1tYWRlLXdpdGgtY3J1c2hlZC1idWdzLTUyMTc5Ny800gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVkMlYyZG10NlFreHRhRlJGVFJDbkFSaXRBaWdCTWdhVlZKREtLUWM=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Pfizer's Xeljanz Combo Comparable to AbbVie's Humira", "desc": null, "date": "17/02/2017", "link": "news.google.com/articles/CBMiXmh0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3BmaXplcnMteGVsamFuei1jb21iby1jb21wYXJhYmxlLWFiYnZpZXMtMTMxMzAxNzM5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTJTMjF4VmpKVVZUaGlaVU51VFJDcEFSaXFBaWdCTWdrSkFZN2tHcXBqY0FF=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Posts Fourth Quarter Numbers", "desc": null, "date": "02/02/2018", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1wb3N0cy1mb3VydGgtcXVhcnRlci1udW1iZXJzLTE1NDgyNzAxOC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUtkMEZMYVRKSVVuVklOekZLVFJDckFSaW1BaWdCTWdPWkFRUQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Submits Supplemental Biologics License Application For Nplate\u00ae (romiplostim)", "desc": null, "date": "19/12/2018", "link": "news.google.com/articles/CBMihwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXN1Ym1pdHMtc3VwcGxlbWVudGFsLWJpb2xvZ2ljcy1saWNlbnNlLWFwcGxpY2F0aW9uLWZvci1ucGxhdGUtcm9taXBsb3N0aW0tMzAwNzY5MTMzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVFiSGxSWTBvM05uQm1aVlZKVFJDaUFSaTJBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The 7 Best Biotech Stocks for Investors Who Hate Risk", "desc": null, "date": "20/09/2018", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LmtpcGxpbmdlci5jb20vc2xpZGVzaG93L2ludmVzdGluZy90MDUyLXMwMDEtNy1iZXN0LWJpb3RlY2gtc3RvY2tzLWZvci1pbnZlc3RvcnMtd2hvLWhhdGUtcmlzay9pbmRleC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXlNVWx0Umw5bFNIRTBURlZSVFJDeEFSaWNBaWdCTWdPQmRBWQ=-w200-h112-p-df", "media": "Kiplinger's Personal Finance", "site": null, "reporter": "James Brumley", "sentiment": "positive"}, {"title": "Why this Peninsula startup is primed for an $80.5 million IPO - San Francisco Business Times", "desc": null, "date": "24/05/2018", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDE4LzA1LzI0L2tlemFyLWxpZmUtc2NpZW5jZXMtYW1nZW4tYW1nbi1vbnl4LWx1cHVzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFORGhuTVZWM1JuVmtUblpxVFJDVEFoaTNBU2dCTWdZZEU1WXNrUW8=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Better Buy: Amgen Inc. vs. Pfizer Inc.", "desc": null, "date": "01/07/2018", "link": "news.google.com/articles/CBMiRWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iZXR0ZXItYnV5LWFtZ2VuLWluYy12cy0xMDMyMDA2NzIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUZWSFYxVURaaFJsaFplRVpFVFJDM0FSaVRBaWdCTWdhdHhZVE9RUVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "Update to Mexico Natural Gas Pipeline Safety Rules Slated for Late August", "desc": null, "date": "09/05/2018", "link": "news.google.com/articles/CBMiamh0dHBzOi8vd3d3Lm5hdHVyYWxnYXNpbnRlbC5jb20vdXBkYXRlLXRvLW1leGljby1uYXR1cmFsLWdhcy1waXBlbGluZS1zYWZldHktcnVsZXMtc2xhdGVkLWZvci1sYXRlLWF1Z3VzdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1kekpKTkRKVk5XOTNZM2N3VFJDUUFSamRBaWdCTWdhTklwSnBtUWc=-w200-h112-p-df", "media": "Natural Gas Intelligence", "site": null, "reporter": "Peter De Montmollin", "sentiment": "negative"}, {"title": "AbbVie's Stock Hit By Citron Tweet - AbbVie (NYSE:ABBV)", "desc": null, "date": "19/07/2018", "link": "news.google.com/articles/CBMiKWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzEyMDQ1MzY00gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzEyMDQ1MzY0?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Wayne Duggan", "sentiment": "negative"}, {"title": "Why a kidney disease drug approval in China is just the start for this S.F. company - San Francisco Business Times", "desc": null, "date": "18/12/2018", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDE4LzEyLzE4L2ZpYnJvZ2VuLWNoaW5hLXJveGFkdXN0YXQta2lkbmV5LWNrZC1mZ2VuLWFtZ24uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZWbkpOU25oTVNTMTBOMjloVFJDb0FSaXJBaWdCTWdZQmtJd3N1Z1U=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "positive"}, {"title": "3 Reasons Gilead Sciences Is a Better Value Stock Than Amgen", "desc": null, "date": "03/06/2018", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy8zLXJlYXNvbnMtZ2lsZWFkLXNjaWVuY2VzLWJldHRlci0xMzMzMDA5NDUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpabEJ6T1VjNVIzWnlhRTR0VFJDM0FSaVRBaWdCTWdZcG9vWVV2UVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "New Class of Migraine Drug Creates Four-Way Pharma Development Race - Eli Lilly and Co (NYSE:LLY), iShare", "desc": null, "date": "06/09/2018", "link": "news.google.com/articles/CBMiKWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzEyMjg0NTgw0gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzEyMjg0NTgw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "shanthi rexaline", "sentiment": "positive"}, {"title": "3 Biotech Stocks With Rising Earnings Estimates Post Q4", "desc": null, "date": "13/03/2018", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzLzMtYmlvdGVjaC1zdG9ja3MtcmlzaW5nLWVhcm5pbmdzLTE1MDQwMzc1MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUliV3BJWVVoS2VuaGxSblpyVFJDeEFSaWNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Falls 3%", "desc": null, "date": "03/12/2018", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLWZhbGxzLTMtMjAzNjAyMjc2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXVUSEp6TURJeFJsOW5YMmxKVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AstraZeneca gets FDA breakthrough therapy label for asthma treatment", "desc": null, "date": "07/09/2018", "link": "news.google.com/articles/CBMigQFodHRwczovL2NhLm1vdmllcy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FzdHJhemVuZWNhLWdldHMtZmRhLWJyZWFrdGhyb3VnaC10aGVyYXB5LWxhYmVsLWFzdGhtYS10cmVhdG1lbnQtMDYyNTQwOTEwLS1maW5hbmNlLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBPRGxFYUhSVU4za3lZbGN4VFJDM0FSaVRBaWdCTWdZSk1KS21vQW8=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": "Nivedita Balu", "sentiment": "negative"}, {"title": "Exclusive: Big Pharma returning to U.S. price hikes in January after pause", "desc": null, "date": "19/12/2018", "link": "news.google.com/articles/CBMib2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvZXhjbHVzaXZlLWJpZy1waGFybWEtcmV0dXJuaW5nLXUtcHJpY2UtaGlrZXMtamFudWFyeS0wMDQ4MjE4MDUtLWZpbmFuY2UuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXFhVmhGZEV0alFsOUViMUZ4VFJDLUFSaUtBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Roche (RHHBY) Gets FDA Approval for Cobas EFGR Mutation Test", "desc": null, "date": "24/08/2018", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3JvY2hlLXJoaGJ5LWdldHMtZmRhLWFwcHJvdmFsLTEzMzgwMTAwOC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVhSR3M0VkVvNFVHbFNjSHBaVFJEQ0FSaURBaWdCTWdZQkFJVFZvQWs=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Novartis' Lutathera Gets FDA Approval for Pancreatic Tumors", "desc": null, "date": "29/01/2018", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9ub3ZhcnRpcy1hcG9zLWx1dGF0aGVyYS1nZXRzLWZkYS0yMTE0MDk1NjguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDRPVTVaZDJOTk1sTkJkMmhMVFJEQ0FSaURBaWdCTWdZWllJd3ZMUWs=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib", "desc": null, "date": "21/12/2018", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9hYmJ2aWUtYWJidi1zZWVrcy1hcHByb3ZhbC1yYS0xOTUyMDc0NzcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVWVkIwZWtOeUxUWXhhbXRMVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia (denosumab) To Patients With Glucocorticoid ...", "desc": null, "date": "30/04/2018", "link": "news.google.com/articles/CBMitQFodHRwczovL3d3dy5teW5ld3NkZXNrLmNvbS9zZS9hbWdlbi9wcmVzc3JlbGVhc2VzL2FtZ2VuLXJlY2VpdmVzLXBvc2l0aXZlLWNobXAtb3Bpbmlvbi10by1leHBhbmQtdXNlLW9mLXByb2xpYS1kZW5vc3VtYWItdG8tcGF0aWVudHMtd2l0aC1nbHVjb2NvcnRpY29pZC1pbmR1Y2VkLW9zdGVvcG9yb3Npcy0yNDkzNjc20gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFORVpEVTFneGRFOXBNMnBwVFJDb0FSaXNBaWdCTWdZQlE0UUpJZ2c=-w200-h112-p-df", "media": "Mynewsdesk", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature", "desc": null, "date": "30/10/2019", "link": "news.google.com/articles/CBMilAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3RoZS1kaXNjb3Zlcnktb2YtYW1nZW5zLW5vdmVsLWludmVzdGlnYXRpb25hbC1rcmFzZzEyYy1pbmhpYml0b3ItYW1nLTUxMC1wdWJsaXNoZWQtaW4tbmF0dXJlLTMwMDk0ODY2NC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXpNbkJ5YzJwdGJWaDFTeTF1VFJER0FSai1BU2dCTWdhWmM1Q05yUVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (AMGN) Q2 2019 earnings report", "desc": null, "date": "30/07/2019", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nZW4tYW1nbi1zdG9jay1xMi0yMDE5LWVhcm5pbmdzLXJlc3VsdHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZkR1V4Wnpod1VEQnFVQzFMVFJDa0FoaXRBU2dCTWdZQlFZYlNuQWM=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Top Biosimilar Drug Companies (NVS, AMGN)", "desc": null, "date": "25/06/2019", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vbmV3cy90b3AtYmlvc2ltaWxhci1kcnVnLWNvbXBhbmllcy1udnMtYW1nbi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURTRnBsYUc5c1JIUjRRbkJ2VFJEQ0FSaUVBaWdCTWdZQkFJSVFwUVk=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Shobhit Seth", "sentiment": "positive"}, {"title": "Amgen: This Industry Leader Remains Undervalued", "desc": null, "date": "30/01/2019", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAxOS8wMS8zMC9hbWdlbi10aGlzLWluZHVzdHJ5LWxlYWRlci1yZW1haW5zLXVuZGVydmFsdWVkL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVhMGgxTVROUFpYYzFXVkp1VFJEQ0FSaURBaWdCTWdZVk1vRXJYUUk=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "David Trainer", "sentiment": "negative"}, {"title": "Does Amgen Inc.'s (NASDAQ:AMGN) CEO Salary Compare Well With Others?", "desc": null, "date": "30/10/2019", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL3N0eWxlL2RvZXMtYW1nZW4taW5jLW5hc2RhcS1hbWduLTEwMzMxMTA2OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpWSEJFZFVWSVNGTk5TMWRvVFJDSEFSajFBaWdCTWdhQkFZYlZnQXc=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "World's largest biotech company to move up to BioMed's big South City project - San Francisco Business Times", "desc": null, "date": "09/12/2019", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDE5LzEyLzA5L2FtZ2VuLWJpb21lZC1nYXRld2F5LW9mLXBhY2lmaWMtYW1nbi1ibGFja3N0b25lLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTFZbVZJUlV4WGRqZEhPVzFhVFJDb0FSaXJBaWdCTWdNQm9RWQ=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "positive"}, {"title": "Amgen (AMGN) Q1 2019 earnings", "desc": null, "date": "30/04/2019", "link": "news.google.com/articles/CBMiOWh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nZW4tYW1nbi1xMS0yMDE5LWVhcm5pbmdzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUZkbVEzU3pKS1pFcEVhM1YxVFJDa0FoaXRBU2dCTWdZQlFJYkZwQVk=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biotech ETFs Strengthen as Amgen Invests in China's BeiGene", "desc": null, "date": "01/11/2019", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmV0ZnRyZW5kcy5jb20vaW5ub3ZhdGl2ZS1ldGZzLWNoYW5uZWwvYmlvdGVjaC1ldGZzLXN0cmVuZ3RoZW4tYXMtYW1nZW4taW52ZXN0cy1pbi1jaGluYXMtYmVpZ2VuZS_SAXFodHRwczovL3d3dy5ldGZ0cmVuZHMuY29tL2lubm92YXRpdmUtZXRmcy1jaGFubmVsL2Jpb3RlY2gtZXRmcy1zdHJlbmd0aGVuLWFzLWFtZ2VuLWludmVzdHMtaW4tY2hpbmFzLWJlaWdlbmUvYW1wLw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVPVTlWWjNoQmRsODRVVEYxVFJDM0FSaVRBaWdCTWdZQlVJak9yQVE=-w200-h112-p-df", "media": "ETF Trends", "site": null, "reporter": "Max Chen", "sentiment": "negative"}, {"title": "Amgen (AMGN) Q3 Earnings and Revenues Top Estimates", "desc": null, "date": "29/10/2019", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYW1nZW4tYW1nbi1xMy1lYXJuaW5ncy1yZXZlbnVlcy0yMTE1MDkxODAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUNSRWxrT1RsUGNsVXhlVmxOVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's Breakaway from Cancer\u00ae", "desc": null, "date": "16/12/2019", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vd3d3Lm11bHRpdnUuY29tL3BsYXllcnMvRW5nbGlzaC84NTQwOTUxLWFtZ2VuLWJyZWFrYXdheS1mcm9tLWNhbmNlci1uZXctdmlkZW8v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBlbWR0VUZwdFVFOUhkR3cwVFJDR0FSajVBaWdCTWdZaGhJaXMwUU0=-w200-h112-p-df", "media": "MultiVu", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Completes Acquisition Of Otezla\u00ae (apremilast)", "desc": null, "date": "21/11/2019", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tY29tcGxldGVzLWFjcXVpc2l0aW9uLW9mLW90ZXpsYS1hcHJlbWlsYXN0LTMwMDk2MjkzMi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Stocks Hold Against Resistance", "desc": null, "date": "09/12/2019", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vc3RvY2tzLWhvbGQtYWdhaW5zdC1yZXNpc3RhbmNlLTQ3Nzg2MTDSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTBZbnBoU2pWVWNVMWFXRXcxVFJDbkFSaXRBaWdCTWdrRkFZYW1pZW84RXdF=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Gordon Scott", "sentiment": "negative"}, {"title": "Bristol Myers Squibb (BMY) announces Amgen's (AMGN) buy out of Celgene's (CELG) Otezla", "desc": null, "date": "26/08/2019", "link": "news.google.com/articles/CBMiogFodHRwczovL25ld3MuYWxwaGFzdHJlZXQuY29tL2FtZ2VuLWFtZ24tdG8tYWNxdWlyZS1jZWxnZW5lcy1jZWxnLW90ZXpsYS1mb3ItMTMtNC1iaWxsaW9uLWJteS1icmlzdG9sLW15ZXJzLXNxdWliYi1jZWxnZW5lLW1lcmdlci1leHBlY3RlZC10by1jbG9zZS1ieS1lbmQtb2YtMjAxOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZXa0YwTFhKNlgyOUhRMUk1VFJDZkFSaS1BaWdCTWdhQlU1SWlyd2M=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Using Free Cash Flow To Find Value With This ETF", "desc": null, "date": "01/05/2019", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAxOS8wNS8wMS91c2luZy1mcmVlLWNhc2gtZmxvdy10by1maW5kLXZhbHVlLXdpdGgtdGhpcy1ldGYv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlVSHB2TlZZMFpsRmtRM0V4VFJDM0FSaVRBaWdCTWdhUjVvb3BSZ1U=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "David Trainer", "sentiment": "negative"}, {"title": "Amgen's Osteoporosis Drug Evenity Gets Approval in Europe", "desc": null, "date": "12/12/2019", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2Vucy1vc3Rlb3Bvcm9zaXMtZHJ1Zy1ldmVuaXR5LWdldHMtMTQzNjAyODczLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iKkNnNHhOa2QwVHpsV1pVaHpVM2RCVFJCOUdKUURLQUV5QmdrQ2lvVzVCUQ=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA Approves Amgen And Allergan's KANJINTI\u2122 (trastuzumab-anns), A Biosimilar To Herceptin\u00ae (trastuzumab)", "desc": null, "date": "13/06/2019", "link": "news.google.com/articles/CBMimAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1hcHByb3Zlcy1hbWdlbi1hbmQtYWxsZXJnYW5zLWthbmppbnRpLXRyYXN0dXp1bWFiLWFubnMtYS1iaW9zaW1pbGFyLXRvLWhlcmNlcHRpbi10cmFzdHV6dW1hYi0zMDA4Njc2MDMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXpWVGhGT0dOTFZYSjFlbGw0VFJDaUFSaTJBaWdCTWdZQm9KTEdRQWM=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here's Why Amgen Stock Gained 10% in June", "desc": null, "date": "06/07/2019", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2Fwb3Mtd2h5LWFtZ2VuLXN0b2NrLWdhaW5lZC0xNDAwMDA3NTAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUthV0Y0YjI1cFRVTlllbTVrVFJDekFSaVpBaWdCTWdZVm80UlJPUWM=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "Medicines Company Rallies On Positive LDL Cholesterol Study Results", "desc": null, "date": "20/05/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tZWRpY2luZXMtY29tcGFueS1yYWxsaWVzLXBvc2l0aXZlLWxkbC0xMzQyMDkxMDkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVllV2RmUVRJMGFGb3dlRzlTVFJDM0FSaVRBaWdCTWdtUkpJenBRZVZycFFJ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "shanthi rexaline", "sentiment": "negative"}, {"title": "Amgen Earnings, Revenue Beat in Q3", "desc": null, "date": "29/10/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLWVhcm5pbmdzLXJldmVudWUtYmVhdC1xMy0xNjA0MDA0MDUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUJTWEJxTURCU09IQTRMVUkyVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "BeiGene Announces Global Strategic Oncology Collaboration with Amgen", "desc": null, "date": "31/10/2019", "link": "news.google.com/articles/CBMijwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAxOS8xMC8zMS8xOTM5MDgyLzAvZW4vQmVpR2VuZS1Bbm5vdW5jZXMtR2xvYmFsLVN0cmF0ZWdpYy1PbmNvbG9neS1Db2xsYWJvcmF0aW9uLXdpdGgtQW1nZW4uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iKkNnNHdNbTlUTVZWcVgwdzJlVzQzVFJCdUdLd0NLQUV5QmdGUWtBUWpDUQ=-w200-h112-p-df", "media": "GlobeNewswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Merck's Pediatric Filings for Dificid Get FDA's Priority Review", "desc": null, "date": "03/10/2019", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tZXJja3MtcGVkaWF0cmljLWZpbGluZ3MtZGlmaWNpZC1mZGFzLTE1MjIwMzQzNy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVNORmt4YTFscFMzaElNRjgwVFJDeUFSaWJBaWdCTWdhQlpKU0VKZ2c=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen raises 2019 profit, sales view after buying Celgene psoriasis drug", "desc": null, "date": "21/11/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLXJhaXNlcy0yMDE5LXByb2ZpdC1zYWxlcy0xMTQ0MzA2MzAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUlZVGxIYlhKWlNXczFhRjl3VFJDM0FSaVRBaWdCTWdrTklKWkdtdW84S3dJ=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": "Saumya Sibi Joseph & Shinjini Ganguli", "sentiment": "negative"}, {"title": "Stocks - Apple, AMD, Boeing Surge in Premarket, AT&T, Amgen Drop", "desc": null, "date": "30/01/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9zdG9ja3MtYXBwbGUtYW1kLWJvZWluZy1zdXJnZS0wODE4MDAwNzUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWhNVU5VWkZOT1UwWTVNMDV4VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Merck's Pediatric Filings for Dificid Get FDA's Priority Review", "desc": null, "date": "03/10/2019", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL21lcmNrcy1wZWRpYXRyaWMtZmlsaW5ncy1kaWZpY2lkLWZkYXMtMTUyMjAzNDM3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXFhVmhGZEV0alFsOUViMUZ4VFJDLUFSaUtBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Horizon's (HZNP) Eye Disease Drug Gets FDA's Priority Review", "desc": null, "date": "10/09/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2hvcml6b25zLWh6bnAtZXllLWRpc2Vhc2UtZHJ1Zy0xMTU5MTEyMjYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJlWE5ETlhaTVpsSnpkMnN6VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket", "desc": null, "date": "15/09/2020", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tYW5kLW1iYy1iaW9sYWJzLWFubm91bmNlLXdpbm5lcnMtb2YtdGhlLWFtZ2VuLWdvbGRlbi10aWNrZXQtMzAxMTMwNTc3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is Amgen (AMGN) a Good Choice for Dow Membership?", "desc": null, "date": "02/09/2020", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vaXMtYW1nZW4tYW1nbi1hLWdvb2QtY2hvaWNlLWZvci1kb3ctbWVtYmVyc2hpcC01MDc2NTkz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5ORmxyUlMxV1dVZERkbkkxVFJDZUFSaV9BaWdCTWdhQllZanlJQWs=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Alan S. Farley", "sentiment": "negative"}, {"title": "Amgen Joins Dow Jones Industrial Average as the Benchmark Index Revamps to 'Better Reflect' the U.S. Economy", "desc": null, "date": "31/08/2020", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYW1nZW4tam9pbnMtZG93LWpvbmVzLWluZHVzdHJpYWwtYXZlcmFnZS1hcy10aGUtYmVuY2htYXJrLWluZGV4LXJldmFtcHMtdG8tYmV0dGVyLXJlZmxlY3TSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTBlRmxSZW1GYWFWZFdkRm8wVFJEckFSaldBU2dCTWdhaEpJNnRHUWc=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Stock Up 50% But Revenues Grew Just 3%", "desc": null, "date": "14/08/2020", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LnRyZWZpcy5jb20vc3RvY2svYW1nbi9hcnRpY2xlcy80OTYyMzcvYW1nZW4tc3RvY2stdXAtNTAtYnV0LXJldmVudWVzLWdyZXctanVzdC0zLzIwMjAtMDgtMTTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNUZOMUJ5T0hSSU0yNU1VekJCVFJDYkFSakdBaWdCTWdzSkE0cG9yaVU5RUtuVXdB=-w200-h112-p-df", "media": "Trefis", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Better Buy: Biogen vs. Amgen", "desc": null, "date": "15/03/2020", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzAzLzE1L2JldHRlci1idXktYmlvZ2VuLXZzLWFtZ2VuLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhXa0Y0TkdGc2VWVnplR2w2VFJDM0FSaVRBaWdCTWdZSk1vYlZvQWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Adria Cimino", "sentiment": "negative"}, {"title": "Amgen Stock Looks to Break Out After Analyst Upgrade", "desc": null, "date": "30/03/2020", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vYW1nZW4tbG9va3MtdG8tYnJlYWtvdXQtYWZ0ZXItYW5hbHlzdC11cGdyYWRlLTQ4MDEyODTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVVOV3BSTW5oRmVuUTBRVFE0VFJDNUFSaVJBaWdCTWdPQk1SQQ=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Justin Kuepper", "sentiment": "negative"}, {"title": "Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average", "desc": null, "date": "24/08/2020", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjAvMDgvMjQvc2FsZXNmb3JjZS1hbWdlbi1hbmQtaG9uZXl3ZWxsLWFkZGVkLXRvLWRvdy1pbi1tYWpvci1zaGFrZXVwLXRvLXRoZS1hdmVyYWdlLmh0bWzSAXRodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyMC8wOC8yNC9zYWxlc2ZvcmNlLWFtZ2VuLWFuZC1ob25leXdlbGwtYWRkZWQtdG8tZG93LWluLW1ham9yLXNoYWtldXAtdG8tdGhlLWF2ZXJhZ2UuaHRtbA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhUREl4YmpOa2RtWTJWRlUyVFJDb0FSaXNBaWdCTWdhVlFaYklxQWc=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Pippa Stevens", "sentiment": "positive"}, {"title": "Stocks To Watch: Amgen Sees Relative Strength Rating Jump To 83", "desc": null, "date": "02/07/2020", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L3N0b2Nrcy10by13YXRjaC1hbWdlbi1zZWVzLXJlbGF0aXZlLXN0cmVuZ3RoLXJhdGluZy1qdW1wLXRvLTgzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWlla1ZXZW1aMlZYTlpjM2h2VFJDb0FSaXJBaWdCTWdB=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AbbVie Seeks US and EU Nods for Rinvoq for Psoriatic Arthritis", "desc": null, "date": "02/06/2020", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYWJidmllLXNlZWtzLXVzLWV1LW5vZHMtMTU0MzAzMDU3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXFMVXRVUzFWRmNXWjBjMmxQVFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Better Buy: Amgen vs. Johnson & Johnson", "desc": null, "date": "23/04/2020", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA0LzIzL2JldHRlci1idXktYW1nZW4tdnMtam9obnNvbi1qb2huc29uLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZRME0xV1hrd2J6UlZjbFZKVFJDM0FSaVRBaWdCTWdZRlFwQUpKUWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "Way forward unclear for Cytokinetics and Amgen", "desc": null, "date": "16/11/2020", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS93YXktZm9yd2FyZC11bmNsZWFyLWZvci1jeXRva2luZXRpY3MtYW5kLWFtZ2Vu0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkbE55UVZSYU4wbEdkbkV4VFJDM0FSaVRBaWdCTWdZaHBKQ01OUVU=-w200-h112-p-df", "media": "The Pharma Letter", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "IPO Preview: Pandion Therapeutics Starts $75 Million IPO Effort - IPOs On TheStreet - U.S. IPO Research & Opinion", "desc": null, "date": "03/07/2020", "link": "news.google.com/articles/CBMiO2h0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3MvcGFuZGlvbi10aGVyYXBldXRpY3MtaXBv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJiVjgxTnkxUFFqRmFaMnR0VFJDb0FSaXNBaWdCTWdhTm9JeUlPQVU=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Donovan Jones", "sentiment": "negative"}, {"title": "15 Largest Biotech Companies in the World", "desc": null, "date": "18/11/2020", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy8xNS1sYXJnZXN0LWJpb3RlY2gtY29tcGFuaWVzLXdvcmxkLTE0MDM1MDc4My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTBUa0p3UmxRNFpFcG1ja2RKVFJDM0FSaVRBaWdCTWdhMU01cHhtUWs=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Ty Haqqi", "sentiment": "positive"}, {"title": "IPO Launch: Checkmate Pharmaceuticals Proposes $75 Million IPO - IPOs On TheStreet - U.S. IPO Research & Opinion", "desc": null, "date": "04/08/2020", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3MvY2hlY2ttYXRlLXBoYXJtYWNldXRpY2Fscy1pcG8tbGF1bmNo0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJkbXg2Ym5SMGRpMWpXVk42VFJDb0FSaXNBaWdCTWdZQjBJS0dTQUk=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Donovan Jones", "sentiment": "negative"}, {"title": "1 Stock That Crushed the Market During the Last Recession", "desc": null, "date": "10/04/2020", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA0LzEwLzEtc3RvY2stdGhhdC1jcnVzaGVkLXRoZS1tYXJrZXQtZHVyaW5nLXRoZS1sYXN0LXJlLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTRPVGxGVEZWRlNIZENkMFEyVFJDM0FSaVRBaWdCTWdNSmNoSQ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "IPO Launch: Oncorus Targets $87 Million U.S. IPO - IPOs On TheStreet - U.S. IPO Research & Opinion", "desc": null, "date": "28/09/2020", "link": "news.google.com/articles/CBMiNWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3Mvb25jb3J1cy1pcG8tbGF1bmNo0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTFiRnB3T1RSYWVtRlZORGx1VFJDb0FSaXNBaWdCTWdNSnNCQQ=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Donovan Jones", "sentiment": "negative"}, {"title": "GSK to widen COVID-19 antibody treatment trial after safety clearance", "desc": null, "date": "06/10/2020", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvZ3NrLXdpZGVuLWNvdmlkLTE5LWFudGlib2R5LTEyMDc1NjM5Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpSa1pvYUdWVWRrTlFkRkYzVFJDekFSaWFBaWdCTWdZQmhaYkVzUWM=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen to Acquire Rodeo Therapeutics Corporation", "desc": null, "date": "30/03/2021", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tYWNxdWlyZS1yb2Rlby10aGVyYXBldXRpY3MtY29ycG9yYXRpb24tMzAxMjU4OTU3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFZbFp5VUhWVFNXTTFaMWx0VFJDZEFSakFBaWdCTWdrQllJSWpKMms5OWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Option Traders Unenthusiastic Into Earnings", "desc": null, "date": "02/08/2021", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vYW1nZW4tYW1nbi1vcHRpb24tdHJhZGVycy11bmVudGh1c2lhc3RpYy1pbnRvLWVhcm5pbmdzLTUxOTU0MzTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBjM0ZSWjNwMlIzZHplbWxSVFJDeEFSaWNBaWdCTWdZRk1aYktJQWs=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Gordon Scott", "sentiment": "negative"}, {"title": "Amgen Releases 8th Edition of Biosimilar Trends Report", "desc": null, "date": "22/09/2021", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcmVsZWFzZXMtOHRoLWVkaXRpb24tb2YtYmlvc2ltaWxhci10cmVuZHMtcmVwb3J0LTMwMTM4MjE3My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTBTemxPZWtObmNHMW1PVXAwVFJEX0FSakZBU2dCTWdNSkJBdw=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen completes $1.9B acquisition of Five Prime Therapeutics", "desc": null, "date": "16/04/2021", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmRydWdkZWxpdmVyeWJ1c2luZXNzLmNvbS9hbWdlbi1jb21wbGV0ZXMtMS05Yi1hY3F1aXNpdGlvbi1vZi1maXZlLXByaW1lLXRoZXJhcGV1dGljcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUNXR05zY1VSTlRHcEhZV1Z6VFJDMUFSaVhBaWdCTWdPVlVnWQ=-w200-h112-p-df", "media": "Drug Delivery Business News", "site": null, "reporter": "Sean Whooley", "sentiment": "negative"}, {"title": "Amgen Stock Gives Every Indication Of Being Fairly Valued", "desc": null, "date": "31/03/2021", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1zdG9jay1naXZlcy1ldmVyeS1pbmRpY2F0aW9uLTAzMTI0MzQ5Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNW1hbEZDWjFWUVgxZG9UbTVYVFJDdUFSaWlBaWdCTWdPQkJBbw=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "How big is the mid-2020's LOE problem for Amgen?", "desc": null, "date": "17/08/2021", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9ob3ctYmlnLWlzLXRoZS1taWQtMjAyMC1zLWxvZS1wcm9ibGVtLWZvci1hbWdlbtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJVamt3U3pGSFJWWjVPWGx1VFJDM0FSaVRBaWdCTWdZQmdJcXl4QVE=-w200-h112-p-df", "media": "The Pharma Letter", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "JNJ: 4 Top Healthcare Stocks on the Dow Jones Index", "desc": null, "date": "10/08/2021", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2puai11bmgtbXJrLWFtZ24tNC10b3AtaGVhbHRoY2FyZS1zdG9ja3Mtb24tdGhlLWRvdy1qb25lcy1pbmRleC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlkWGxwY1Y4eFJGcExlVlZ4VFJEaEFSamhBU2dCTWdhbFU0ak91UVk=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Pragya Pandey", "sentiment": "positive"}, {"title": "Dow's 150-point jump highlighted by gains in shares of Boeing, Merck", "desc": null, "date": "29/09/2021", "link": "news.google.com/articles/CBMirAFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vc3RvcnkvZG93LXMtMTUwLXBvaW50LWp1bXAtaGlnaGxpZ2h0ZWQtYnktZ2FpbnMtaW4tc2hhcmVzLW9mLWJvZWluZy1tZXJjay0wMTYzMjk0NDgyND9ndWlkPSU3QjIwQzBBNDQ1LTU0RDQtQjU0NS03NTY5LUJERDMwNUZEMEQwRiU3RCZzaXRlaWQ9cnNz0gF5aHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9kYXRhLW5ld3MvZG93LXMtMTUwLXBvaW50LWp1bXAtaGlnaGxpZ2h0ZWQtYnktZ2FpbnMtaW4tc2hhcmVzLW9mLWJvZWluZy1tZXJjay0wMTYzMjk0NDgyNA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFRbGRJU1hOYU5UUkVRa1ZtVFJDakFSaTJBaWdCTWdhVnNwUXJQUWM=-w200-h112-p-df", "media": "MarketWatch", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "In quest to interrupt aging, East Bay biotech lands drug, equity deal with Amgen - San Francisco Business Times", "desc": null, "date": "14/04/2021", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIxLzA0LzE0L2FnaW5nLWFtZ2VuLWFtZ24tYmlvYWdlLWxhYnMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTRWV2hOYlU5bVJITkhhbVpsVFJDb0FSaXNBaWdCTWdZdEpvak5HUW8=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Amgen Stock Gives Every Indication Of Being Fairly Valued", "desc": null, "date": "04/06/2021", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1zdG9jay1naXZlcy1ldmVyeS1pbmRpY2F0aW9uLTAyMDc0Mjk1My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDJSRkJXYzBNMU9IUkplVzFqVFJDdUFSaWlBaWdCTWdNQkJBZw=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen to Acquire Five Prime for $1.9B, Adding Phase III Gastric Cancer Candidate", "desc": null, "date": "04/03/2021", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvYW1nZW4tdG8tYWNxdWlyZS1maXZlLXByaW1lLWZvci0xLTliLWFkZGluZy1waGFzZS1paWktZ2FzdHJpYy1jYW5jZXItY2FuZGlkYXRlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNW5iM1JtU1ZOVk5WbEVZVnB3VFJDM0FSaVRBaWdCTWdrQmtvcGxQcVhnelFF=-w200-h112-p-df", "media": "Genetic Engineering & Biotechnology News", "site": null, "reporter": "Alex Philippidis", "sentiment": "negative"}, {"title": "Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments", "desc": null, "date": "27/07/2021", "link": "news.google.com/articles/CBMiogFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXRvLWFjcXVpcmUtcHJpdmF0ZWx5LWhlbGQtdGVuZW9iaW8tZm9yLTkwMC1taWxsaW9uLWluLWNhc2gtd2l0aC1mdXR1cmUtY29udGluZ2VudC1taWxlc3RvbmUtcGF5bWVudHMtMzAxMzQyNTY1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTZXRFZSUTA5aVJUbEplVTlRVFJDakFSaTFBaWdCTWdNQndCQQ=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "This Could Be the Next Biogen", "desc": null, "date": "27/09/2021", "link": "news.google.com/articles/CBMiO2h0dHBzOi8vcHJvLnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2dpbmtvLWJpb3dvcmtzLTE1NzgwOTI40gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNHRRemhXUW5kNFdrUnZlblZmVFJEaEFSamhBU2dCTWdPQmdRZw=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Timothy Collins", "sentiment": "positive"}, {"title": "Amgen Shares Drop On Light First Quarter Earnings Hit By Lower Prices", "desc": null, "date": "28/04/2021", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1zaGFyZXMtZHJvcC1saWdodC1maXJzdC0xMjM4Mjk0NzMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWpZbUpuZEhWSWFqZExWMlJTVFJDM0FSaVRBaWdCTWdrQkVJZ2x4cVRBOXdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash", "desc": null, "date": "04/03/2021", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tYWNxdWlyZS1maXZlLXByaW1lLXRoZXJhcGV1dGljcy1mb3ItMS05LWJpbGxpb24taW4tY2FzaC0zMDEyNDAzNTguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "How to Find Stocks on Sale in 2021", "desc": null, "date": "13/10/2021", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3Mvc3RvY2tzLXNhbGUtMjAyMS0xNzMxMDUyMTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUhabVZMWjNFeE4wTkdWVE5YVFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": "Tracey Ryniec", "sentiment": "negative"}, {"title": "AbbVie (ABBV) Q4 Earnings & Sales Top, 2021 Outlook Bright", "desc": null, "date": "03/02/2021", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hYmJ2aWUtYWJidi1xNC1lYXJuaW5ncy1zYWxlcy0xNTQ2MDM1NzcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNHdSRVpaYm14MGNUTlJXVkIzVFJDNEFSaVRBaWdCTWdNSkFoZw=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "EXCLUSIVE: Sree Batchu On The Power Of The Los Angeles MedTech Ecosystem, Why You Should Care - Amgen (NA", "desc": null, "date": "11/05/2021", "link": "news.google.com/articles/CBMiiAFodHRwczovL3d3dy5iZW56aW5nYS5jb20vbmV3cy8yMS8wNS8yMTAxMzYzMS9leGNsdXNpdmUtc3JlZS1iYXRjaHUtb24tdGhlLXBvd2VyLW9mLXRoZS1sb3MtYW5nZWxlcy1tZWR0ZWNoLWVjb3N5c3RlbS13aHkteW91LXNob3VsZC1jYXJl0gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzIxMDEzNjMx?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlOM2hZVXkxRlZWcHlUaTFWVFJDM0FSaVRBaWdCTWdhZFI1cEtvZ2s=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Renato Capelj", "sentiment": "negative"}, {"title": "Sanofi (SNY) Gets Label Expansion Nod for Sarclisa in Europe", "desc": null, "date": "19/04/2021", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3Nhbm9maS1zbnktZ2V0cy1sYWJlbC1leHBhbnNpb24tMTMyNTAxNjkxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJlWE5ETlhaTVpsSnpkMnN6VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "7 Dividend Growth Stocks For September 2021 - Dividend Strategists", "desc": null, "date": "02/09/2021", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vZGl2aWRlbmRzdHJhdGVnaXN0cy9kaXZpZGVuZC1pZGVhcy83LWRpdmlkZW5kLWdyb3d0aC1zdG9ja3MtZm9yLXNlcHRlbWJlci0yMDIx0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWhlRmR2V1UxbWQza3RYMDloVFJEaEFSamhBU2dCTWdrQm9Zb0x1YWRGOUFB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ferdi Scheepers", "sentiment": "negative"}, {"title": "ARWR: Multiple Data Readouts in 2021\u2026", "desc": null, "date": "09/02/2021", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vc2NyLnphY2tzLmNvbS9uZXdzL25ld3MtZGV0YWlscy8yMDIxL0FSV1ItTXVsdGlwbGUtRGF0YS1SZWFkb3V0cy1pbi0yMDIxL2RlZmF1bHQuYXNweNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWljbkJaZDJwcWRGRlNRazlvVFJETUFSajNBU2dCTWdtQkE0S0xtYWlLMGdB=-w200-h112-p-df", "media": "Zacks Small Cap Research", "site": null, "reporter": "David Bautz", "sentiment": "negative"}, {"title": "How to Trade the FDA Approval Game", "desc": null, "date": "11/05/2021", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vd3d3LmVuZXJneWFuZGNhcGl0YWwuY29tL2hvdy10by10cmFkZS10aGUtZmRhLWFwcHJvdmFsLWdhbWUv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXpNeTFVYTJGaFUxOTVjRFJXVFJDckFSaW5BaWdCTWdZTlFKenBuQWs=-w200-h112-p-df", "media": "Energy & Capital", "site": null, "reporter": "Christian DeHaemer", "sentiment": "negative"}, {"title": "GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH ...", "desc": null, "date": "07/03/2022", "link": "news.google.com/articles/CBMilwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2dsb2JhbC1iaW90ZWNobm9sb2d5LWxlYWRlci1hbWdlbi1icmVha3MtZ3JvdW5kLW9uLW5ldy1tYW51ZmFjdHVyaW5nLWZhY2lsaXR5LWluLW5vcnRoLWNhcm9saW5hLTMwMTQ5NjkxMi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "What's Driving Growth For Amgen Stock?", "desc": null, "date": "14/12/2022", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8xMi8xNC93aGF0cy1kcml2aW5nLWdyb3d0aC1mb3ItYW1nZW4tc3RvY2sv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVWbE5OYVZsRFUwc3pTbkpRVFJDM0FSaVRBaWdCTWdhaG81S011UVk=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN: Amgen is Our Growth Stock of the Week\u2026", "desc": null, "date": "12/10/2022", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tYW1nZW4taXMtb3VyLWdyb3d0aC1zdG9jay1vZi10aGUtd2Vlay01NzY5MDIyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhaM2xtVGtsb01qaDFaaTF4VFJDakFSaTJBaWdCTWdZMUlJVHp3QU0=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Jaimini Desai", "sentiment": "positive"}, {"title": "Amgen (AMGN) Gets $28.5B Bridge Loan to Fund Horizon Therapeutics (HZNP) Deal", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIyLTEyLTEyL2FtZ2VuLWFtZ24tc2VjdXJlcy1icmlkZ2UtbG9hbi10by1mdW5kLWhvcml6b24tdGhlcmFwZXV0aWNzLWh6bnAtYWNxdWlzaXRpb27SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhYekpITjFFM2IzcDJUbU5EVFJDb0FSaXNBaWdCTWdhWjhvWkxVUU0=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Josyana Joshua", "sentiment": "negative"}, {"title": "AMGEN AND GENERATE BIOMEDICINES ANNOUNCE MULTI-TARGET, MULTI-MODALITY RESEARCH ...", "desc": null, "date": "06/01/2022", "link": "news.google.com/articles/CBMinQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFuZC1nZW5lcmF0ZS1iaW9tZWRpY2luZXMtYW5ub3VuY2UtbXVsdGktdGFyZ2V0LW11bHRpLW1vZGFsaXR5LXJlc2VhcmNoLWNvbGxhYm9yYXRpb24tYWdyZWVtZW50LTMwMTQ1NTE1Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen dives deeper into rare disease drugs with $27.8 bln Horizon deal", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL21hcmtldHMvZGVhbHMvYW1nZW4tc2V0LWJ1eS1iaW90ZWNoLWZpcm0taG9yaXpvbi0yNi1ibG4tdmFsdWF0aW9uLWJsb29tYmVyZy1uZXdzLTIwMjItMTItMTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXdSR3RWTkU1UFpFdDBPVWx0VFJDM0FSaVRBaWdCTWdhWmNaVHhMQWM=-w200-h112-p-df", "media": "Reuters", "site": null, "reporter": "Manas Mishra & Bhanvi Satija", "sentiment": "negative"}, {"title": "Amgen to buy Horizon Therapeutics in $26.4 billion deal", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjIvMTIvMTIvYW1nZW4tdG8tYnV5LWhvcml6b24tdGhlcmFwZXV0aWNzLWluLTI2cG9pbnQ0LWJpbGxpb24tZGVhbC5odG1s0gFjaHR0cHM6Ly93d3cuY25iYy5jb20vYW1wLzIwMjIvMTIvMTIvYW1nZW4tdG8tYnV5LWhvcml6b24tdGhlcmFwZXV0aWNzLWluLTI2cG9pbnQ0LWJpbGxpb24tZGVhbC5odG1s?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTNiVEZtTXpFMGR6ZFhRWFkwVFJDb0FSaXNBaWdCTWdZTk1JNUZuZ2s=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Gains But Lags Market: What You Should Know", "desc": null, "date": "04/04/2022", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9hbWdlbi1hbWduLWdhaW5zLWxhZ3MtbWFya2V0LTIyMTUxMDQzOS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxiMnhTUTJKRmNrNVFibDlWVFJES0FSajZBU2dCTWdhWmNZeHN1UVU=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Outlines Growth Strategy Through 2030", "desc": null, "date": "08/02/2022", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LnN0cmVldGluc2lkZXIuY29tL0NvcnBvcmF0ZStOZXdzL0FtZ2VuKyUyOEFNR04lMjkrT3V0bGluZXMrR3Jvd3RoK1N0cmF0ZWd5K1Rocm91Z2grMjAzMC8xOTU3Mzg2MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXlWbGRDUTJacGRFNVNTR2MwVFJESUFSaklBU2dCTWdNSnNCUQ=-w200-h112-p-df", "media": "StreetInsider.com", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN AND ARRAKIS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO IDENTIFY NOVEL RNA ...", "desc": null, "date": "11/01/2022", "link": "news.google.com/articles/CBMitQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFuZC1hcnJha2lzLXRoZXJhcGV1dGljcy1hbm5vdW5jZS1tdWx0aS10YXJnZXQtY29sbGFib3JhdGlvbi10by1pZGVudGlmeS1ub3ZlbC1ybmEtZGVncmFkZXItc21hbGwtbW9sZWN1bGUtdGhlcmFwZXV0aWNzLTMwMTQ1ODM4MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iKkNnNUxWV2hQVTAxVWQxUldSSFp2VFJCd0dNY0JLQUV5QnAyamxJdTVCZw=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Do Options Traders Know Something About Amgen (AMGN) Stock We Don't?", "desc": null, "date": "20/10/2022", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9vcHRpb25zLXRyYWRlcnMta25vdy1zb21ldGhpbmctYW1nZW4tMTI1MDEyODQ4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHhSakpPYkVnd2FqTnVVRGR0VFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY OF ABP 654, BIOSIMILAR ...", "desc": null, "date": "18/04/2022", "link": "news.google.com/articles/CBMiqwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFubm91bmNlcy1wb3NpdGl2ZS10b3AtbGluZS1yZXN1bHRzLWZyb20tcGhhc2UtMy1zdHVkeS1vZi1hYnAtNjU0LWJpb3NpbWlsYXItY2FuZGlkYXRlLXRvLXN0ZWxhcmEtdXN0ZWtpbnVtYWItMzAxNTI3MzMzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (NASDAQ:AMGN) shareholders have earned a 7.3% CAGR over the last five years", "desc": null, "date": "23/09/2022", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYW1nZW4tbmFzZGFxLWFtZ24tc2hhcmVob2xkZXJzLWVhcm5lZC0xMjAxMDkwMzYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022", "desc": null, "date": "08/08/2022", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtbmV3LXRhcmxhdGFtYWItY2xpbmljYWwtZGF0YS1hdC13Y2xjLTIwMjItMzAxNjAxNzY3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS", "desc": null, "date": "03/11/2022", "link": "news.google.com/articles/CBMiamh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcmVwb3J0cy10aGlyZC1xdWFydGVyLTIwMjItZmluYW5jaWFsLXJlc3VsdHMtMzAxNjY4MjI2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN PRESENTS NEW PHASE 2 DATA THAT SHOW OLPASIRAN DELIVERS SIGNIFICANT REDUCTION IN ...", "desc": null, "date": "06/11/2022", "link": "news.google.com/articles/CBMioQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXByZXNlbnRzLW5ldy1waGFzZS0yLWRhdGEtdGhhdC1zaG93LW9scGFzaXJhbi1kZWxpdmVycy1zaWduaWZpY2FudC1yZWR1Y3Rpb24taW4tbGlwb3Byb3RlaW5hLWxldmVscy0zMDE2NjkxNDYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW REPATHA\u00ae (EVOLOCUMAB) DATA AT AHA 2022", "desc": null, "date": "07/11/2022", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtbmV3LXJlcGF0aGEtZXZvbG9jdW1hYi1kYXRhLWF0LWFoYS0yMDIyLTMwMTY3MDU1NS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRibDlVTW5aaFpYWmljbFJuVFJDc0FSaW1BaWdCTWdhQndZRFR5QVE=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "LUMAKRAS\u00ae (SOTORASIB) RECEIVES APPROVAL IN JAPAN FOR PATIENTS WITH KRAS G12C-MUTATED ...", "desc": null, "date": "20/01/2022", "link": "news.google.com/articles/CBMirQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2x1bWFrcmFzLXNvdG9yYXNpYi1yZWNlaXZlcy1hcHByb3ZhbC1pbi1qYXBhbi1mb3ItcGF0aWVudHMtd2l0aC1rcmFzLWcxMmMtbXV0YXRlZC1hZHZhbmNlZC1ub24tc21hbGwtY2VsbC1sdW5nLWNhbmNlci0zMDE0NjQ2OTcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen says IRS seeks billions in back taxes, shares fall 6%", "desc": null, "date": "27/04/2022", "link": "news.google.com/articles/CBMiemh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2FtZ2VuLXNheXMtaXJzLXNlZWtzLWFub3RoZXItNTEtYmlsbGlvbi1iYWNrLXRheGVzLTIwMjItMDQtMjcv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTFSMGxTZEZCU2JYUXpNM0o2VFJDM0FSaVRBaWdCTWdrTklKWkdHcW84NndF=-w200-h112-p-df", "media": "Reuters", "site": null, "reporter": "Deena Beasley", "sentiment": "negative"}, {"title": "Why Amgen (AMGN) Might Surprise This Earnings Season", "desc": null, "date": "25/04/2022", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vYXUubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3doeS1hbWdlbi1hbWduLW1pZ2h0LXN1cnByaXNlLTEyNDQxMjk2Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNURlRUp1V21WalNYbEhRa05JVFJDY0FSakNBaWdCTWdzQkVKaUFoMnRFQ1lvQnVR=-w200-h112-p-df", "media": "Yahoo News Australia", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is Amgen Stock a Buy Now?", "desc": null, "date": "20/10/2022", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzEwLzIwL2lzLWFtZ2VuLXN0b2NrLWEtYnV5LW5vdy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXljeTFsVmpkSllYbE9OVXhZVFJDM0FSaVRBaWdCTWdhSllaUWxLUWs=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "David Jagielski", "sentiment": "negative"}, {"title": "Global biotech breaks ground on 355-job Holly Springs facility. Here's when hiring will ramp up. - Triangle Business ...", "desc": null, "date": "07/03/2022", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS90cmlhbmdsZS9uZXdzLzIwMjIvMDMvMDcvYW1nZW4tYnJlYWtzLWdyb3VuZC1vbi1ob2xseS1zcHJpbmdzLXNpdGUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXJjV2hwZEVFd2RtOHlVbVpXVFJDb0FSaXNBaWdCTWdNQmdBUQ=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Zac Ezzone", "sentiment": "negative"}, {"title": "How This Obesity Underdog Is Creeping Up On Novo, Lilly", "desc": null, "date": "01/12/2022", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2FtZ2VuLXN0b2NrLWhvdy1pdHMtb2Jlc2l0eS10cmVhdG1lbnQtaXMtY3JlZXBpbmctdXAtb24tbm92by1saWxseS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFUR1EyTmpsUE0zVlJNbkExVFJDb0FSaXNBaWdCTWdhQmNaTFZwQWM=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "HZNP Stock Rockets As Amgen Agrees To Buy Horizon Therapeutics For $27.8 Billion", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2h6bnAtc3RvY2stcm9ja2V0cy1hcy1hbWdlbi1hZ3JlZXMtdG8tYnV5LWhvcml6b24tdGhlcmFwZXV0aWNzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDRaMlpDZEVaTWNIaHFlVzFhVFJDb0FSaXJBaWdCTWdNUlJDQQ=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Amgen's short, big move designed to execute at corner of tech and biotech - San Francisco Business Times", "desc": null, "date": "06/10/2022", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIyLzEwLzA2L2FtZ2VuLWFtZ24tY2FuY2VyLXNvdXRoLXNhbi1mcmFuY2lzY28uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9hMWQwV1VGRFZGSk5UR1ZrVFJDb0FSaXNBaWdCTWdZUmdJNkxyUWM=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "positive"}, {"title": "Amgen Stock Jumps After Narrowing Race In Obesity Treatment With Novo, Lilly", "desc": null, "date": "08/11/2022", "link": "news.google.com/articles/CBMidmh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2FtZ2VuLXN0b2NrLWp1bXBzLWFmdGVyLW5hcnJvd2luZy1yYWNlLWluLW9iZXNpdHktdHJlYXRtZW50LXdpdGgtbm92by1saWxseS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWhjalJzWkRKQ1pFSmhWWEpOVFJDb0FSaXNBaWdCTWdtRmNKU1h0Q2JCekFF=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "A Congressman Just Sold JPMorgan Stock Ahead Of Earnings: See Two Dividend Stocks He Is Also Trading", "desc": null, "date": "11/10/2022", "link": "news.google.com/articles/CBMingFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9hLWNvbmdyZXNzbWFuLWp1c3Qtc29sZC1qcG1vcmdhbi1zdG9jay1haGVhZC1vZi1lYXJuaW5ncy1zZWUtdHdvLWRpdmlkZW5kLXN0b2Nrcy1oZS1pcy1hbHNvLXRyYWRpbmctMTAzMTc5NjcwONIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVhYelkzV1MxM1UxaHZaRlJEVFJEQ0FSaURBaWdCTWdZVldKWm9wZ2c=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "CCXI Stock Rockets; Amgen Plans $3.7 Billion ChemoCentryx Buyout As Generics Loom", "desc": null, "date": "04/08/2022", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2NjeGktc3RvY2stcm9ja2V0cy1hcy1hbWdlbi1wbGFucy1jaGVtb2NlbnRyeXgtdGFrZW92ZXIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDNVRlJYVVVrdFFrSjBVM2swVFJDb0FSaXNBaWdCTWdrTmdwU0dMaWc5NndF=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "7 Pharmaceutical Stocks That Could Make You Rich", "desc": null, "date": "06/01/2022", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMi8wMS83LXBoYXJtYWNldXRpY2FsLXN0b2Nrcy10aGF0LWNvdWxkLW1ha2UteW91LXJpY2gv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTNlVFZETlROb1dFdHVlbE0wVFJDb0FSaXNBaWdCTWdrQkFJaEJFR1dSZ3dN=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Tezcan Gecgil", "sentiment": "negative"}, {"title": "MRTX Stock Crashes As Amgen Rivalry Heats Up With New Lung Cancer Data", "desc": null, "date": "06/12/2022", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L21ydHgtc3RvY2stY3Jhc2hlcy1hcy1hbWdlbi1yaXZhbHJ5LWhlYXRzLXVwLXdpdGgtbmV3LWx1bmctY2FuY2VyLWRhdGEv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFjMVI1WkZOeVh6ZzRPRlZuVFJDcEFSaXJBaWdCTWdZQkFZaWdnd3c=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "How Covid, 'industrial logic' and a threat played out in a multibillion-dollar biotech merger - San Francisco Business ...", "desc": null, "date": "01/09/2022", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIyLzA5LzAxL2FtZ2VuLWNoZW1vY2VudHJ5eC1hbWduLWNjeGktdGF2bmVvcy1tZXJnZXItYnV5b3V0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9URkJzYm13MmNtTXdVRGw0VFJDb0FSaXNBaWdCTWdhdFZaRE9xUWM=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "ATHA: Forget Athira Pharma, Pick Up These 4 Top-Rated Biotech Stocks Instead", "desc": null, "date": "06/07/2022", "link": "news.google.com/articles/CBMic2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2F0aGEtdnJ0eC1hbWduLXV0aHItc2JobXktZm9yZ2V0LWF0aGlyYS1waGFybWEtcGljay11cC10aGVzZS00LXRvcC1yYXRlZC1iaW90ZWNoLXN0b2Nrcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVSV1pXVEdSUVFXaHRiazUzVFJDM0FSaVRBaWdCTWdZRllwQUdNUWM=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Sweta Vijayan", "sentiment": "negative"}, {"title": "The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug ...", "desc": null, "date": "20/01/2022", "link": "news.google.com/articles/CBMi0AFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy90aGUtZGFpbHktYmlvdGVjaC1wdWxzZS1ub3ZhdmF4LWNvdmlkLXNob3QtYXV0aG9yaXplZC1pbi1hdXN0cmFsaWEtenltZXdvcmtzLXJlc3RydWN0dXJlcy1vcnBoYW4tZHJ1Zy1kZXNpZ25hdGlvbi1mb3ItbWFya2VyLXMtcGFuY3JlYXRpYy1jYW5jZXItZHJ1Zy0xMDMxMTE2MDAw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXlVVmh4YTA1T2IycHRiMkpzVFJEQ0FSaURBaWdCTWdrRlk0ekVKdWxqTXdF=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Top Research Reports for Novo Nordisk, Amgen & ADP", "desc": null, "date": "16/11/2022", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3RvcC1yZXNlYXJjaC1yZXBvcnRzLW5vdm8tbm9yZGlzay0yMTI2MDkxOTUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNiSGwxVFcxQ1prbGpaMEV0VFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "The 7 Best Retirement Stocks to Buy Now", "desc": null, "date": "18/12/2022", "link": "news.google.com/articles/CBMiMWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vYmVzdC1yZXRpcmVtZW50LXN0b2Nrcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFkREk1WjNoeFIwOUZkMUZzVFJDb0FSaXNBaWdCTWdZbEZZeXRrUWs=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Louis Navellier", "sentiment": "positive"}, {"title": "The 7 Best Biotech Stocks to Buy", "desc": null, "date": "20/09/2022", "link": "news.google.com/articles/CBMiLmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vYmVzdC1iaW90ZWNoLXN0b2Nrcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhNREZ1WVZSYWJHRXplbk5RVFJDb0FSaXNBaWdCTWdZSmNwQXdLUWM=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Dana Blankenhorn", "sentiment": "positive"}, {"title": "Top 7 Dividend Growth Stock Picks for 2022 - Dividend Strategists", "desc": null, "date": "03/01/2022", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vZGl2aWRlbmRzdHJhdGVnaXN0cy9kaXZpZGVuZC1pZGVhcy90b3AtNy1kaXZpZGVuZC1ncm93dGgtc3RvY2stcGlja3MtZm9yLTIwMjLSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBObnB5UlY5b1ZIVkdOVXB6VFJEQ0FSaURBaWdCTWdhTkVaVG9xUWM=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ferdi Scheepers", "sentiment": "positive"}, {"title": "7 Dividend Growth Stocks For January 2022 - Dividend Strategists", "desc": null, "date": "18/01/2022", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vZGl2aWRlbmRzdHJhdGVnaXN0cy9kaXZpZGVuZC1pZGVhcy83LWRpdmlkZW5kLWdyb3d0aC1zdG9ja3MtZm9yLWphbnVhcnktMjAyMtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdlVGR3U1c1c1ZUZzFlWGg0VFJEQ0FSaURBaWdCTWdZNUlJbzZEQXM=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ferdi Scheepers", "sentiment": "negative"}, {"title": "AMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION", "desc": null, "date": "14/12/2023", "link": "news.google.com/articles/CBMid2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tYW5ub3VuY2VzLWV4ZWN1dGl2ZS1hcHBvaW50bWVudHMtdG8tYWNjZWxlcmF0ZS1pbm5vdmF0aW9uLTMwMjAxNTM5MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know", "desc": null, "date": "22/12/2023", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnZlc3RvcnMtaGVhdmlseS1zZWFyY2gtYW1nZW4taW5jLTE0MDAwNjc4NC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHdhamQ2ZVd4eWJGTjFVWGM1VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS\u00ae (SOTORASIB) FOR THE TREATMENT OF KRAS G12C ...", "desc": null, "date": "21/08/2023", "link": "news.google.com/articles/CBMiuwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXRvLWRpc2N1c3MtYXBwbGljYXRpb24tZm9yLWx1bWFrcmFzLXNvdG9yYXNpYi1mb3ItdGhlLXRyZWF0bWVudC1vZi1rcmFzLWcxMmMtcG9zaXRpdmUtbnNjbGMtYXQtZmRhLWFkdmlzb3J5LWNvbW1pdHRlZS1tZWV0aW5nLTMwMTkwNTk1Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know", "desc": null, "date": "17/11/2023", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1hdHRyYWN0aW5nLWludmVzdG9yLTE0MDAwNTcxOC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVpWMEpTVFhGWVdFUnlNbUZQVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer", "desc": null, "date": "13/12/2023", "link": "news.google.com/articles/CBMilwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1ncmFudHMtcHJpb3JpdHktcmV2aWV3LXRvLWFtZ2Vucy10YXJsYXRhbWFiLWFwcGxpY2F0aW9uLWZvci1hZHZhbmNlZC1zbWFsbC1jZWxsLWx1bmctY2FuY2VyLTMwMjAxNDYzOS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here's Why Amgen (AMGN) is a Strong Value Stock", "desc": null, "date": "11/12/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktYW1nZW4tYW1nbi1zdHJvbmctMTQ0MDA3OTg1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXBNakZFWDBaUGRWQlRUMjVJVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN'S ...", "desc": null, "date": "09/05/2023", "link": "news.google.com/articles/CBMilwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFuZC10c2Nhbi10aGVyYXBldXRpY3MtYW5ub3VuY2UtY29sbGFib3JhdGlvbi10by1pZGVudGlmeS1ub3ZlbC10YXJnZXRzLWluLWNyb2hucy1kaXNlYXNlLTMwMTgxODU1Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iLkNnNVhXVVJvYUVrMGF6RkxZbXBvVFJCMUdKQURLQUV5Q1FFZ2dLSWFLa1ZKQWc=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (NASDAQ:AMGN) shareholders have earned a 9.8% CAGR over the last five years", "desc": null, "date": "07/12/2023", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1uYXNkYXEtYW1nbi1zaGFyZWhvbGRlcnMtZWFybmVkLTExMDA1ODg1OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023", "desc": null, "date": "16/10/2023", "link": "news.google.com/articles/CBMihwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXRvLXByZXNlbnQtbmV3LXJlc2VhcmNoLWZyb20tb25jb2xvZ3ktcG9ydGZvbGlvLWFuZC1waXBlbGluZS1hdC1lc21vLTIwMjMtMzAxOTU2ODUwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "FDA Rejects Amgen's (AMGN) NDA Seeking Full Nod for Lumakras", "desc": null, "date": "27/12/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9mZGEtcmVqZWN0cy1hbWdlbnMtYW1nbi1uZGEtMTYwOTAwMjA0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFjamMwT1ZwMU5tMUxRV05WVFJDeUFSaWJBaWdCTWdZWlU0b3NKUVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023", "desc": null, "date": "26/08/2023", "link": "news.google.com/articles/CBMid2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtbGF0ZS1icmVha2luZy1waGFzZS0yLW9scGFzaXJhbi1kYXRhLWF0LWVzYy0yMDIzLTMwMTkxMDQzNi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Amgen Inc (AMGN) Stock Fairly Valued?", "desc": null, "date": "08/08/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1zdG9jay1mYWlybHktMTYzMzQwMzg0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJSMlZQTjBFMk4yZGFOMjl5VFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA GRANTS FULL APPROVAL FOR BLINCYTO\u00ae (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE ...", "desc": null, "date": "21/06/2023", "link": "news.google.com/articles/CBMiwwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1ncmFudHMtZnVsbC1hcHByb3ZhbC1mb3ItYmxpbmN5dG8tYmxpbmF0dW1vbWFiLXRvLXRyZWF0LW1pbmltYWwtcmVzaWR1YWwtZGlzZWFzZS1wb3NpdGl2ZS1iLWNlbGwtcHJlY3Vyc29yLWFjdXRlLWx5bXBob2JsYXN0aWMtbGV1a2VtaWEtMzAxODU2MTI4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here's Why We Think Amgen (NASDAQ:AMGN) Might Deserve Your Attention Today", "desc": null, "date": "11/12/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktdGhpbmstYW1nZW4tbmFzZGFxLTEzMDAxMzQyOS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN ANNOUNCES CARDIOVASCULAR STUDY TO EVALUATE ASSOCIATION BETWEEN LIPOPROTEIN(a) AND ...", "desc": null, "date": "22/02/2023", "link": "news.google.com/articles/CBMitgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFubm91bmNlcy1jYXJkaW92YXNjdWxhci1zdHVkeS10by1ldmFsdWF0ZS1hc3NvY2lhdGlvbi1iZXR3ZWVuLWxpcG9wcm90ZWluYS1hbmQtY2FyZGlvdmFzY3VsYXItcmlzay1pbi1hZnJpY2FuLWFtZXJpY2Fucy0zMDE3NTIxNDkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "The Amgen Inc (AMGN) Company: A Short SWOT Analysis", "desc": null, "date": "02/11/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1jb21wYW55LXNob3J0LTA1MDgwODMyMi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript October 31, 2023", "desc": null, "date": "01/11/2023", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtbmFzZGFxLWFtZ24tcTMtMTQzMTQ4ODA2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUphbEV0WW1zNVoyNWtYMUExVFJDb0FSaXNBaWdCTWdZWkpvUm9sZ2s=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Insider Monkey", "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023", "desc": null, "date": "10/11/2023", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtbmV3LWNhcmRpb3Zhc2N1bGFyLXJlc2VhcmNoLWF0LWFoYS0yMDIzLTMwMTk4NDEyNC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?", "desc": null, "date": "16/10/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWJlYXQtZXN0aW1hdGVzLWFnYWluLTE2MTAxMDU0My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVdaSGd0V0RkVFdtbzRjMUl3VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Stock Moves -0.15%: What You Should Know", "desc": null, "date": "29/12/2023", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXN0b2NrLW1vdmVzLTAtMjI1MDIwNTE5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWFNVVIwVFV4a2FHVjRjRWhIVFJDM0FSaVRBaWdCTWdZbEJwRHNBUTA=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) shareholders have earned a 5.8% CAGR over the last five years", "desc": null, "date": "07/07/2023", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1uYXNkYXEtYW1nbi1zaGFyZWhvbGRlcnMtZWFybmVkLTEyMDAzODk1My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (NASDAQ:AMGN) Seems To Use Debt Quite Sensibly", "desc": null, "date": "28/07/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1uYXNkYXEtYW1nbi1zZWVtcy1kZWJ0LTEyMDA0NjYzMC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlObXRQY2toalptNXBialZOVFJDMEFSaVpBaWdCTWdZTkFZelZDQXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc (AMGN) Q3 2023 Earnings: Revenue Up 4% to $6.9 Billion, GAAP EPS Down 19% to $3.22", "desc": null, "date": "31/10/2023", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1xMy0yMDIzLTEyMzI1NDIzNC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFUMU5RYTFseVdYZHNURFpmVFJEaEFSamhBU2dCTWdZRnNaVFVQQWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJ\u00d6GREN'S SYNDROME AT ACR 2023", "desc": null, "date": "07/11/2023", "link": "news.google.com/articles/CBMikgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXByZXNlbnRzLW5ldy1kYXRhLWZyb20tcGhhc2UtMi10cmlhbC1vZi1kYXpvZGFsaWJlcC1pbi1zam9ncmVucy1zeW5kcm9tZS1hdC1hY3ItMjAyMy0zMDE5NzkyMDguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is Amgen Stock a Buy Now?", "desc": null, "date": "17/12/2023", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzEyLzE3L2lzLWFtZ2VuLXN0b2NrLWEtYnV5LW5vdy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNiRU4xVVZKSldrRnpOalY0VFJDM0FSaVRBaWdCTWdhUmxvUUhzZ1k=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Sales Drive Profit Guidance Even as New Drugs Falter", "desc": null, "date": "03/08/2023", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTA4LTAzL2FtZ2VuLWFtZ24tcmFpc2VzLTIwMjMtcHJvZml0LXNhbGVzLWd1aWRhbmNlLWV2ZW4tYXMta2V5LWRydWdzLWZhbHRlctIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtaa1JQVURNNVNYcEhaMG8zVFJDM0FSaVRBaWdCTWdZTmtvcE1NUWM=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Ike Swetlitz", "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) Gains on New AWS Partnership - TipRanks.com", "desc": null, "date": "28/11/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FtZ2VuLW5hc2RhcWFtZ24tZ2FpbnMtd2l0aC1uZXctYXdzLXBhcnRuZXJzaGlw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVBjVXA1TjNGc0xWZ3RWMTh4VFJDbEFSaXhBaWdCTWdhZHM1S0x1UVk=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Steve Anderson", "sentiment": "negative"}, {"title": "Is Amgen Stock Fully Valued After A 17% Rise In A Month?", "desc": null, "date": "14/08/2023", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8wOC8xNC9pcy1hbWdlbi1zdG9jay1mdWxseS12YWx1ZWQtYWZ0ZXItYS0xNy1yaXNlLWluLWEtbW9udGgv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpablUzUlVwRE1qaFNRVWRVVFJDM0FSaVRBaWdCTWdhRjlJYnBTUVE=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more", "desc": null, "date": "11/10/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMTAvMTEvc3RvY2tzLW1ha2luZy10aGUtYmlnZ2VzdC1tb3Zlcy1taWRkYXktLmh0bWzSAVBodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyMy8xMC8xMS9zdG9ja3MtbWFraW5nLXRoZS1iaWdnZXN0LW1vdmVzLW1pZGRheS0uaHRtbA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVJhRXN0TXpGQldtOVVaMDAzVFJDb0FSaXNBaWdCTWdrWkE1QXh0U2FTcFFJ=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Michelle Fox", "sentiment": "positive"}, {"title": "Investment Ideas: AMGN Near Buy Point With Strong Fundamentals and Rising Dividend", "desc": null, "date": "16/02/2023", "link": "news.google.com/articles/CBMibWh0dHBzOi8vdHJhZGV0aGF0c3dpbmcuY29tL2ludmVzdG1lbnQtaWRlYXMtYW1nbi1uZWFyLWJ1eS1wb2ludC13aXRoLXN0cm9uZy1mdW5kYW1lbnRhbHMtYW5kLXJpc2luZy1kaXZpZGVuZC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVNNWEF4ZEdWaWRIcE9kMW96VFJDYUFSakhBaWdCTWdNQmt4SQ=-w200-h112-p-df", "media": "TradeThatSwing", "site": null, "reporter": "Cory Mitchell", "sentiment": "positive"}, {"title": "AMGN: Amgen (AMGN) Earnings Watch: Buy or Sell?", "desc": null, "date": "30/10/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tZ2lsZC1qYXp6LWFsa3MtYW1nZW4tYW1nbi1lYXJuaW5ncy13YXRjaC1idXktb3Itc2VsbC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUpTRU4wUzAxSFlrTlRXa1UxVFJDNkFSaU9BaWdCTWdPSnNSSQ=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Dipanjan Banchur", "sentiment": "negative"}, {"title": "Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value", "desc": null, "date": "10/10/2023", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXZhbHVhdGlvbi1jb21wcmVoZW5zaXZlLWFuYWx5c2lzLTE1MzYxNDI1MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN)'s True Worth: A Complete Analysis of Its Market Value", "desc": null, "date": "20/09/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXRydWUtd29ydGgtY29tcGxldGUtMjMzMjU1NjMwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Top Stock Reports for McDonald's, Amgen & NextEra Energy", "desc": null, "date": "29/11/2023", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90b3Atc3RvY2stcmVwb3J0cy1tY2RvbmFsZHMtYW1nZW4tMTk1MjAwMDk5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVFNMEo1VGpWbWJGY3hZVUU1VFJDM0FSaVRBaWdCTWdrQmdJU0F4R05UMlFB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Sheraz Mian", "sentiment": "positive"}, {"title": "Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised", "desc": null, "date": "04/08/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXEyLWVhcm5pbmdzLWJlYXQtMTYxMjAwMjAzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpVbWd5TlU1WlRqVTBkek5tVFJDeUFSaWJBaWdCTWdhTk40cUdIZ1k=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN TO PRESENT NEW REPATHA\u00ae (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC", "desc": null, "date": "01/03/2023", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tcHJlc2VudC1uZXctcmVwYXRoYS1ldm9sb2N1bWFiLWFuZC1vbHBhc2lyYW4tZGF0YS1hdC1hY2MtMzAxNzU5MTQxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNNMU14WjJ0clVsOWhVVWhSVFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Stock (AMGN) Stock Falls on Sales Guidance", "desc": null, "date": "31/10/2023", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTEwLTMxL2FtZ2VuLXJhaXNlcy1yZXZlbnVlLWd1aWRhbmNlLWFmdGVyLWNsb3NpbmctaG9yaXpvbi1wdXJjaGFzZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVSUzFHVWt0M1pqRnZaekp1VFJDM0FSaVRBaWdCTWdZQlFwSU9wUWM=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Ike Swetlitz", "sentiment": "negative"}, {"title": "Is Amgen Stock a Top Buy and Hold?", "desc": null, "date": "21/08/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA4LzIxL2lzLWFtZ2VuLXN0b2NrLWEtdG9wLWJ1eS1hbmQtaG9sZC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNUZka0ZqTWpKMmFXWnBVV0UzVFJDM0FSaVRBaWdCTWdzQklKREFIR2dzSkN0b2RB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "Which Is A Better Pick \u2013 Abbott Stock Or Amgen?", "desc": null, "date": "16/10/2023", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8xMC8xNi93aGljaC1pcy1hLWJldHRlci1waWNrLS1hYmJvdHQtc3RvY2stb3ItYW1nZW4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTNhbXhTWHpoVlJFcGpOWGxEVFJDM0FSaVRBaWdCTWdheFlJelNLQVU=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Which Is A Better Pick \u2013 Honeywell Stock Or Amgen?", "desc": null, "date": "11/09/2023", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8wOS8xMS93aGljaC1pcy1hLWJldHRlci1waWNrLS1ob25leXdlbGwtc3RvY2stb3ItYW1nZW4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZXbEU0Um1GU1dFTjJjSFZNVFJDM0FSaVRBaWdCTWdhcDFJaXVSUVE=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts", "desc": null, "date": "24/10/2023", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8xMC9hbWdlbi1sYXlvZmZzLTIwMjMtd2hhdC10by1rbm93LWFib3V0LXRoZS1sYXRlc3QtYW1nbi1qb2ItY3V0cy0yL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDBXakZEVmtKSmRHdHZZMmxaVFJDb0FSaXNBaWdCTWdrQlFJQUgxaUZyU1FJ=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Chris Macdonald", "sentiment": "negative"}, {"title": "AMGN Earnings: Everything you need to know about Amgen\u2019s Q2 results", "desc": null, "date": "04/08/2023", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nbi1lYXJuaW5ncy1ldmVyeXRoaW5nLXlvdS1uZWVkLXRvLWtub3ctYWJvdXQtYW1nZW5zLXEyLXJlc3VsdHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUdTRUpGUVhKRGJuVm1RbGxLVFJDa0FoaXRBU2dCTWdZQk1ZaklKQVk=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) Delivers Better-than-Expected Q3 Earnings - TipRanks.com", "desc": null, "date": "31/10/2023", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FtZ2VuLW5hc2RhcWFtZ24tZGVsaXZlcnMtYmV0dGVyLXRoYW4tZXhwZWN0ZWQtcTMtZWFybmluZ3PSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhlazF2V2taVFZHcFVhR0pmVFJDbEFSaXhBaWdCTWdZQlFKQ3VMUVk=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Shrilekha Pethe", "sentiment": "negative"}, {"title": "US Challenge to Amgen Deal Threatens Big Pharma Business Model", "desc": null, "date": "16/05/2023", "link": "news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTA1LTE2L2Z0Yy1jaGFsbGVuZ2UtdG8tYW1nZW4tYW1nbi1ob3Jpem9uLWRlYWwtdGhyZWF0ZW5zLWJpZy1waGFybWEtYnVzaW5lc3MtbW9kZWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNVBXRjkyWmtoWFYyazFUWEJDVFJDM0FSaVRBaWdCTWdzQnNJU3JQV1k5OUZoc1RR=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Ike Swetlitz", "sentiment": "negative"}, {"title": "Amgen Inc's Dividend Analysis", "desc": null, "date": "15/11/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmNzLWRpdmlkZW5kLWFuYWx5c2lzLTEwMDYxMTQ3OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN: 3 Biotech Stocks Beating BioMarin Pharmaceutical (BMRN)", "desc": null, "date": "16/11/2023", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tdnJ0eC1qYXp6LWJtcm4tMy1iaW90ZWNoLXN0b2Nrcy1iZWF0aW5nLWJpb21hcmluLXBoYXJtYWNldXRpY2FsLWJtcm4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtZMmwyWVcxVU1VUnpVR2hzVFJDakFSaTJBaWdCTWdZTkJZS3VrUWs=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Dipanjan Banchur", "sentiment": "negative"}, {"title": "AMGN Earnings: Everything you need to know about Amgen\u2019s Q1 results", "desc": null, "date": "28/04/2023", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nbi1lYXJuaW5ncy1ldmVyeXRoaW5nLXlvdS1uZWVkLXRvLWtub3ctYWJvdXQtYW1nZW5zLXExLXJlc3VsdHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtkRzFSUWpOZmNVZG9SRk5LVFJDa0FoaXRBU2dCTWdZQk1ZakdKQVk=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why Amgen Shares Are Trading Lower Today", "desc": null, "date": "28/04/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktYW1nZW4tc2hhcmVzLXRyYWRpbmctbG93ZXItMTQ1ODQxMzY0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtkbkYxWnkxMUxWY3RaelZNVFJDb0FSaXNBaWdCTWdhTm9aSXZ2UVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here's Why Intuit Stock Is A Better Pick Over Amgen", "desc": null, "date": "03/10/2023", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8xMC8wMy9oZXJlcy13aHktaW50dWl0LXN0b2NrLWlzLWEtYmV0dGVyLXBpY2stb3Zlci1hbWdlbi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUZZV05YYlV4dlNHaGtRVFUyVFJDMkFSaVVBaWdCTWdZSmc0eG9yUWM=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN Earnings: Highlights of Amgen\u2019s Q3 2023 financial results", "desc": null, "date": "31/10/2023", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nbi1lYXJuaW5ncy1oaWdobGlnaHRzLW9mLWFtZ2Vucy1xMy0yMDIzLWZpbmFuY2lhbC1yZXN1bHRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUJRMjVHTjBvdFNWOVVjVzFrVFJDa0FoaXRBU2dCTWdrQk1ZYktwT1d4Q2dJ=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Lilly (LLY), Pfizer (PFE), Amgen (AMGN) Crowd Into Hot Obesity Drug Market", "desc": null, "date": "13/01/2023", "link": "news.google.com/articles/CBMidWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTAxLTEzL2xpbGx5LWxseS1wZml6ZXItcGZlLWFtZ2VuLWFtZ24tY3Jvd2QtaW50by1ob3Qtb2Jlc2l0eS1kcnVnLW1hcmtldNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZWR3hrYzFwa1VIVmpSRlJDVFJDdkFSaWdBaWdCTWdhQkJKVE5nUXM=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Emma Court & Robert Langreth", "sentiment": "negative"}, {"title": "Amgen (AMGN) Dips More Than Broader Markets: What You Should Know", "desc": null, "date": "09/01/2023", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLWFtZ24tZGlwcy1tb3JlLWJyb2FkZXItMjI1MDEwMjM1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVpWMEpTVFhGWVdFUnlNbUZQVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Can Amgen's Price Strength Continue Into 2024?", "desc": null, "date": "29/12/2023", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vcHJvLnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2Nhbi1hbWdlbi1zLXByaWNlLXN0cmVuZ3RoLWNvbnRpbnVlLWludG8tMjAyNC0xNjE0MTA1NNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXlNRXBhVEc5aVJVZFdRbTh0VFJEd0FSalNBU2dCTWdrQklZcm1sQ2xrRFFF=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Bruce Kamich", "sentiment": "negative"}, {"title": "Is Amgen a Good Dividend Stock?", "desc": null, "date": "01/06/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA2LzAxL2lzLWFtZ2VuLWEtZ29vZC1kaXZpZGVuZC1zdG9jay_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWZMVlJsTFc1WWJGaGxNRWxHVFJDM0FSaVRBaWdCTWdrSlJKU0Z1aVprSmdJ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "Which Is A Better Pick \u2013 PepsiCo Stock Or Amgen?", "desc": null, "date": "26/09/2023", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8wOS8yNi93aGljaC1pcy1hLWJldHRlci1waWNrLS1wZXBzaWNvLXN0b2NrLW9yLWFtZ2VuL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNUZaa3hGUldaUE5XRnpVazV1VFJDM0FSaVRBaWdCTWdzQklJcUVKS1lzVkVua3VR=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Amgen Inc (AMGN) Company: A Short SWOT Analysis", "desc": null, "date": "02/11/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3Lmd1cnVmb2N1cy5jb20vbmV3cy8yMTE2NzU1L3RoZS1hbWdlbi1pbmMtYW1nbi1jb21wYW55LWEtc2hvcnQtc3dvdC1hbmFseXNpc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "GuruFocus.com", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts", "desc": null, "date": "30/01/2023", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wMS9hbWdlbi1sYXlvZmZzLTIwMjMtd2hhdC10by1rbm93LWFib3V0LXRoZS1sYXRlc3QtYW1nbi1qb2ItY3V0cy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDBXakZEVmtKSmRHdHZZMmxaVFJDb0FSaXNBaWdCTWdrQlFJQUgxaUZyU1FJ=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Shrey Dua", "sentiment": "negative"}, {"title": "3 Biotech Stocks You'll Regret Not Buying Soon", "desc": null, "date": "08/08/2023", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wOC8zLWJpb3RlY2gtc3RvY2tzLXlvdWxsLXJlZ3JldC1ub3QtYnV5aW5nLXNvb24v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iNkNnNHdhVVozYlc1T0xXdHVPVU4xVFJDb0FSaXNBaWdCTWc0QklvaENxU1JVNVlva05scWtIQQ=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Michael Que", "sentiment": "negative"}, {"title": "Amgen (AMGN) Appoints Matthew C. Busch as Chief Accounting Officer", "desc": null, "date": "04/08/2023", "link": "news.google.com/articles/CBMigQFodHRwczovL3d3dy5zdHJlZXRpbnNpZGVyLmNvbS9Db3Jwb3JhdGUrTmV3cy9BbWdlbislMjhBTUdOJTI5K0FwcG9pbnRzK01hdHRoZXcrQy4rQnVzY2grYXMrQ2hpZWYrQWNjb3VudGluZytPZmZpY2VyLzIxOTk3NjMyLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXlWbGRDUTJacGRFNVNTR2MwVFJESUFSaklBU2dCTWdNSnNCUQ=-w200-h112-p-df", "media": "StreetInsider.com", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "3 Biotech Stocks to Buy in the TradeSmith 'Green Zone'", "desc": null, "date": "21/12/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8xMi8zLWJpb3RlY2gtc3RvY2tzLXRvLWJ1eS1pbi10aGUtdHJhZGVzbWl0aC1ncmVlbi16b25lL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNXJSbE5DUVhWUE9ETTJkM05TVFJDb0FSaXNBaWdCTWdzQkFJVEZvT1lzQlV2c1hB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) to Slash More Jobs in Second Round of Layoffs - TipRanks.com", "desc": null, "date": "17/03/2023", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FtZ2VuLW5hc2RhcWFtZ24tdG8tc2xhc2gtbW9yZS1qb2JzLWluLXNlY29uZC1yb3VuZC1vZi1sYXlvZmZz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXNRa0pWVjNBNU1YVmFkbTV3VFJDbEFSaXhBaWdCTWdhQllZd3Z1UVU=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Sirisha Bhogaraju", "sentiment": "negative"}, {"title": "Why Amgen (AMGN) is a Top Value Stock for the Long-Term", "desc": null, "date": "28/08/2023", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3doeS1hbWdlbi1hbWduLXRvcC12YWx1ZS0xMzQwMDQ5MTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVNMEZNYWs0dE1uSkxaWGszVFJDaUFSaTNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick", "desc": null, "date": "06/06/2023", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3ZhbHVlLWludmVzdG9yLTEtc3RvY2stY291bGQtMTM0MDA3MTUzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNRVUpQYjJkbFkzbDJlSFYzVFJDakFSaTFBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. : Is the AMGN Stock Price Hinting At $300 This Year?", "desc": null, "date": "17/07/2023", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vdGhlbWFya2V0cGVyaW9kaWNhbC5jb20vMjAyMy8wNy8xNy9hbWdlbi1pbmMtaXMtdGhlLWFtZ24tc3RvY2stcHJpY2UtaGludGluZy1hdC0zMDAtdGhpcy15ZWFyL9IBamh0dHBzOi8vdGhlbWFya2V0cGVyaW9kaWNhbC5jb20vMjAyMy8wNy8xNy9hbWdlbi1pbmMtaXMtdGhlLWFtZ24tc3RvY2stcHJpY2UtaGludGluZy1hdC0zMDAtdGhpcy15ZWFyLz9hbXA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVaMjV4U0RsellrMDJWMlJ4VFJDb0FSaXNBaWdCTWdZUmNZZ3VPUVk=-w200-h112-p-df", "media": "The Market Periodical", "site": null, "reporter": "Nancy J. Allen", "sentiment": "negative"}, {"title": "Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year", "desc": null, "date": "11/03/2023", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vYXUubGlmZXN0eWxlLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYW1nZW5zLW5hc2RhcS1hbWduLXNoYXJlaG9sZGVycy1yZWNlaXZlLTEyMjk1MjAxMi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUtZbGd3YlZJMmJITXhPVGt4VFJDd0FSaWVBaWdCTWdrVkFwQXZqV2VMelFF=-w200-h112-p-df", "media": "Yahoo Lifestyle Australia", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock", "desc": null, "date": "15/02/2023", "link": "news.google.com/articles/CBMicmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wMi93aHktYmlsbGlvbmFpcmVzLXBhdWwtdHVkb3Itam9uZXMtYW5kLWdlb3JnZS1zb3Jvcy1ib3VnaHQtdXAtaG9yaXpvbi1oem5wLXN0b2NrL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlWM0JrTVVac01YTmxUSEJMVFJDb0FSaXNBaWdCTWdhUk1ZU01XUUk=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Larry Ramer", "sentiment": "negative"}, {"title": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings", "desc": null, "date": "16/01/2023", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYm9vc3QtcG9ydGZvbGlvLXRvcC1tZWRpY2FsLXN0b2Nrcy0xNDAwMDI5MDMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNXbVoyT1RoRmNuaEhWVWRNVFJESUFSajlBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Oppenheimer Reiterates AMGEN (AMGN) Outperform Recommendation", "desc": null, "date": "18/05/2023", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3Lm1zbi5jb20vZW4tdXMvbW9uZXkvdG9wc3RvY2tzL29wcGVuaGVpbWVyLXJlaXRlcmF0ZXMtYW1nZW4tYW1nbi1vdXRwZXJmb3JtLXJlY29tbWVuZGF0aW9uL2FyLUFBMWJuUDBl0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUZYekp6Um1sTGVGOVhjR2hOVFJDZEFSaXNBaWdCTWdrdGdJWVJSR01sN1FF=-w200-h112-p-df", "media": "MSN", "site": null, "reporter": "George Maybach", "sentiment": "negative"}, {"title": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcmVwb3J0cy1mb3VydGgtcXVhcnRlci1hbmQtZnVsbC15ZWFyLTIwMjMtZmluYW5jaWFsLXJlc3VsdHMtMzAyMDU1MTMxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It", "desc": null, "date": "12/02/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi10cmVuZGluZy1zdG9jay0xNDAwMDU0OTkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJObEo1Y2xoMmVEQjZObGw0VFJDM0FSaVRBaWdCTWdZQlFvNXdOUWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock", "desc": null, "date": "06/03/2024", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9rbm93LWJleW9uZC13aHktYW1nZW4taW5jLTE0MDAxMDczMy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9YMEpFWm1Wd1ZqVjVha2s0VFJDM0FSaVRBaWdCTWdZQmNJNExNZ2M=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO", "desc": null, "date": "26/02/2024", "link": "news.google.com/articles/CBMiemh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tb3BlbnMtc3RhdGUtb2YtdGhlLWFydC1iaW9tYW51ZmFjdHVyaW5nLXNpdGUtaW4tY2VudHJhbC1vaGlvLTMwMjA3MDE2MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTVjRjl6Y2xRMVQzQk5jVGwwVFJDaUFSaTNBaWdCTWdNRm9SSQ=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It", "desc": null, "date": "03/01/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi10cmVuZGluZy1zdG9jay0xNDAwMDY1MDAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxiMnhTUTJKRmNrNVFibDlWVFJES0FSajZBU2dCTWdhWmNZeHN1UVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know", "desc": null, "date": "23/02/2024", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1hdHRyYWN0aW5nLWludmVzdG9yLTE0MDAxMDE2OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRUblZtTjI5NVl5MWFVMnBRVFJEQ0FSaURBaWdCTWdZcFJZN05JUWc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Inc. (AMGN) Soars to 52-Week High, Time to Cash Out?", "desc": null, "date": "25/01/2024", "link": "news.google.com/articles/CBMiRWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1zb2Fycy01Mi0xNDE1MDQxNjUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUlVSFZzUkZKaFRXNDJTWGd5VFJDeUFSaWJBaWdCTWdrdEFvd3Z0U1U5QUFN=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know", "desc": null, "date": "18/03/2024", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnZlc3RvcnMtaGVhdmlseS1zZWFyY2gtYW1nZW4taW5jLTEzMDAxMTU0My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXhUVlpLV1RGelZUaGtXa3RhVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (AMGN) Down 6.5% Since Last Earnings Report: Can It Rebound?", "desc": null, "date": "07/03/2024", "link": "news.google.com/articles/CBMiQWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWRvd24tNi01LTE2MzEwMzQzNi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhjemQwUWsxdVpWcE9SWEo0VFJDM0FSaVRBaWdCTWdhQnNJeGtRZ1k=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "desc": null, "date": "30/01/2024", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWVhcm5pbmdzLWV4cGVjdGVkLWdyb3ctMTUwMDQ5NDQyLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNU5lVjkxTW1KclQySmlaMGxSVFJDNkFSaVBBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Ascends While Market Falls: Some Facts to Note", "desc": null, "date": "25/03/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWFzY2VuZHMtd2hpbGUtbWFya2V0LTIxNTAxOTM1OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVljblZMWkRkblRYQjFka3hMVFJDM0FSaVRBaWdCTWdZTlFaTFVMQWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (AMGN) Falls More Steeply Than Broader Market: What Investors Need to Know", "desc": null, "date": "04/03/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWZhbGxzLW1vcmUtc3RlZXBseS0yMjUwMTg1MzguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUlYMFJVVVRKT0xWUTFOMmhWVFJDM0FSaVVBaWdCTWdrVkFvb0xQYVUxZ0FN=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why Amgen (AMGN) Outpaced the Stock Market Today", "desc": null, "date": "18/03/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktYW1nZW4tYW1nbi1vdXRwYWNlZC1zdG9jay0yMjAwMTgzNzUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1jbGswYzBWRFVFNDFTWGRIVFJDM0FSaVRBaWdCTWdZSllJb0xxZ2c=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Why the Market Dipped But Amgen (AMGN) Gained Today", "desc": null, "date": "04/01/2024", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktbWFya2V0LWRpcHBlZC1hbWdlbi1hbWduLTIzMDAxODk5NC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVpWMEpTVFhGWVdFUnlNbUZQVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9kcnVnLWJpb3RlY2gtc3RvY2tzLXE0LWVhcm5pbmdzLTE1MDkwMDE4OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhjR2RtWTJKQ1FqYzRNSEphVFJDeUFSaWJBaWdCTWdZTk1wcjBuQWs=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biotech Stock Roundup: GILD, AMGN & BMY's Q4 Results, MOR Up on NVS Deal & More", "desc": null, "date": "08/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW90ZWNoLXN0b2NrLXJvdW5kdXAtZ2lsZC1hbWduLTE1NTYwMDU2Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1lVVJ6ZGtaTWFYVXdXamRQVFJDeUFSaWJBaWdCTWdZWjBJZ0tSUVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc (AMGN) Reports Strong Revenue Growth Amidst Horizon Acquisition", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1yZXBvcnRzLXN0cm9uZy0yMTUyMzAzODEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFUMU5RYTFseVdYZHNURFpmVFJEaEFSamhBU2dCTWdZRnNaVFVQQWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Unlocking Q4 Potential of Amgen (AMGN): Exploring Wall Street Estimates for Key Metrics", "desc": null, "date": "01/02/2024", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy91bmxvY2tpbmctcTQtcG90ZW50aWFsLWFtZ2VuLWFtZ24tMTQxNTIxNDA1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNRVUpQYjJkbFkzbDJlSFYzVFJDakFSaTFBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Q4 Earnings and Revenues Top Estimates", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXE0LWVhcm5pbmdzLXJldmVudWVzLTIyMTAwNDU1My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVNMEZNYWs0dE1uSkxaWGszVFJDaUFSaTNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Reports Q4 Earnings: What Key Metrics Have to Say", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXJlcG9ydHMtcTQtZWFybmluZ3MtMDEwMDA2NzM1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXhUVlpLV1RGelZUaGtXa3RhVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why the Market Dipped But Amgen (AMGN) Gained Today", "desc": null, "date": "11/03/2024", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktbWFya2V0LWRpcHBlZC1hbWdlbi1hbWduLTIxNTAxNzk0MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXdSR2xPVjFCRVh6aERUVzkyVFJEZEFSamtBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now", "desc": null, "date": "16/02/2024", "link": "news.google.com/articles/CBMiiwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hbWduL2FtZ2VuL25ld3MvcGlubmluZy1kb3duLWFtZ2VuLWluY3MtbmFzZGFxYW1nbi1wZS1pcy1kaWZmaWN1bHQtcmlnaHQtbm930gGPAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWFtZ24vYW1nZW4vbmV3cy9waW5uaW5nLWRvd24tYW1nZW4taW5jcy1uYXNkYXFhbWduLXBlLWlzLWRpZmZpY3VsdC1yaWdodC1ub3cvYW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Amgen Stock a Buy Now?", "desc": null, "date": "01/02/2024", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDI0LzAyLzAxL2lzLWFtZ2VuLXN0b2NrLWEtYnV5LW5vdy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdhSFoxUW5SNmVXWlViV014VFJDM0FSaVRBaWdCTWdhSlZaak5wUWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Sees 2024 Revenue Jump After Horizon Therapeutics Purchase", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDI0LTAyLTA2L2FtZ2VuLWV4cGVjdHMtYS0yMDI0LXNhbGVzLWp1bXAtc2V0cy1zaWdodHMtb24tb2Jlc2l0eS1tYXJrZXTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNVBXRjkyWmtoWFYyazFUWEJDVFJDM0FSaVRBaWdCTWdzQnNJU3JQV1k5OUZoc1RR=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Madison Muller", "sentiment": "negative"}, {"title": "AMGN: AMGN Earnings Spotlight: Analyzing Potential Gains", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24taW5jeS1vdHNreS1jb3J0LWFtZ24tZWFybmluZ3Mtc3BvdGxpZ2h0LWFuYWx5emluZy1wb3RlbnRpYWwtZ2FpbnMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpXRmcxY3pCRE9VcFhVemhJVFJDM0FSaVRBaWdCTWdhUllZSVFwUWM=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Anushka Mukherjee", "sentiment": "negative"}, {"title": "Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit", "desc": null, "date": "21/02/2024", "link": "news.google.com/articles/CBMiiwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hbWduL2FtZ2VuL25ld3MvYW1nZW5zLW5hc2RhcWFtZ24tc2hhcmVob2xkZXJzLW1heS13YW50LXRvLWRpZy1kZWVwZXItdGhhbi1z0gGPAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWFtZ24vYW1nZW4vbmV3cy9hbWdlbnMtbmFzZGFxYW1nbi1zaGFyZWhvbGRlcnMtbWF5LXdhbnQtdG8tZGlnLWRlZXBlci10aGFuLXMvYW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) Slips as Obesity Drugs Take Center Stage - TipRanks.com", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FtZ2VuLW5hc2RhcWFtZ24tc2xpcHMtb2Jlc2l0eS1kcnVncy10YWtlLWNlbnRlci1zdGFnZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTBRVTFtTVdOcGRIcFFiWFZuVFJDbEFSaXhBaWdCTWdZQkFvcE13UVE=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Steve Anderson", "sentiment": "negative"}, {"title": "Amgen (AMGN) Q4 Earnings Top, Horizon Drugs Drive Sales", "desc": null, "date": "07/02/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyMjI2MDkvYW1nZW4tYW1nbi1xNC1lYXJuaW5ncy10b3AtaG9yaXpvbi1kcnVncy1kcml2ZS1zYWxlc9IBYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9hbXAvc3RvY2svbmV3cy8yMjIyNjA5L2FtZ2VuLWFtZ24tcTQtZWFybmluZ3MtdG9wLWhvcml6b24tZHJ1Z3MtZHJpdmUtc2FsZXM?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZUMlpMVm1sTk4zaG5RMDlwVFJDeUFSaWJBaWdCTWdhUmNZaUlwZ2c=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs", "desc": null, "date": "26/02/2024", "link": "news.google.com/articles/CBMimwFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9hbWdlbi1zLXVwY29taW5nLWNhdGFseXN0cy1pbi0yMDI0LXNldC10by11bmxvY2stbXVsdGktYmlsbGlvbi1kb2xsYXItbWFya2V0cy1zYXlzLWdvbGRtYW4tc2FjaHMtMTAzMzEwNDEyONIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJlbmxKYlVnd01YZGpjREpYVFJEQ0FSaURBaWdCTWdhQmdZb2t4Z1E=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "June 2025 Options Now Available For Amgen (AMGN)", "desc": null, "date": "12/03/2024", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvanVuZS0yMDI1LW9wdGlvbnMtbm93LWF2YWlsYWJsZS1mb3ItYW1nZW4tYW1nbtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXpkMkpNUVdSdmNXSmplazgwVFJDM0FSaVRBaWdCTWdPQlFnSQ=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Insiders Sold US$5.8m Of Shares Suggesting Hesitancy", "desc": null, "date": "14/03/2024", "link": "news.google.com/articles/CBMihwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hbWduL2FtZ2VuL25ld3MvYW1nZW4taW5zaWRlcnMtc29sZC11czU4bS1vZi1zaGFyZXMtc3VnZ2VzdGluZy1oZXNpdGFuY3nSAYsBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy91cy9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uYXNkYXEtYW1nbi9hbWdlbi9uZXdzL2FtZ2VuLWluc2lkZXJzLXNvbGQtdXM1OG0tb2Ytc2hhcmVzLXN1Z2dlc3RpbmctaGVzaXRhbmN5L2FtcA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Top Research Reports for NVIDIA, Visa & Amgen", "desc": null, "date": "28/02/2024", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90b3AtcmVzZWFyY2gtcmVwb3J0cy1udmlkaWEtdmlzYS0xODQyMDA2NDMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtlaTFmT1dOVlpqSjVOa2d0VFJDeUFSaWJBaWdCTWdhQkk0Z3V6UU0=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Mark Vickery", "sentiment": "positive"}, {"title": "AMGN: Analyzing 3 Biotech Stocks for 2024 Gain Potential", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tdnJ0eC1hbGtzLW52by1hbmFseXppbmctMy1iaW90ZWNoLXN0b2Nrcy1mb3ItMjAyNC1nYWluLXBvdGVudGlhbC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVkRlV0Y0c1TFdtbzVXbU5RVFJDM0FSaVRBaWdCTWdhQllwUnVvUWc=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Kritika Sarmah", "sentiment": "negative"}, {"title": "The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca", "desc": null, "date": "15/01/2024", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy96YWNrcy1hbmFseXN0LWJsb2ctaGlnaGxpZ2h0cy1lbGktMTA1MDAwMTIyLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTbWxZWTJKcVVEQm9TVmxPVFJDeUFSaWJBaWdCTWdhQnNvb3R3UVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note", "desc": null, "date": "19/03/2024", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyNDMwNzcvYW1nZW4tYW1nbi1hc2NlbmRzLWJ1dC1yZW1haW5zLWJlaGluZC1tYXJrZXQtc29tZS1mYWN0cy10by1ub3Rl0gFsaHR0cHM6Ly93d3cuemFja3MuY29tL2FtcC9zdG9jay9uZXdzLzIyNDMwNzcvYW1nZW4tYW1nbi1hc2NlbmRzLWJ1dC1yZW1haW5zLWJlaGluZC1tYXJrZXQtc29tZS1mYWN0cy10by1ub3Rl?hl=en-US&gl=US&ceid=US%3Aen", "img": null, "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza", "desc": null, "date": "11/01/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy94ZXJpcy14ZXJzLWxpY2Vuc2luZy1kZWFsLWFtZ2VuLTEzMzAwMDEyNC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUpibkpOYUc0M1RIRXhUVFphVFJDeUFSaWJBaWdCTWdNSkFBUQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN vs. LLY: Which Biotech Stock Is a Better Buy Right Now?", "desc": null, "date": "15/02/2024", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vd3d3LmJhcmNoYXJ0LmNvbS9zdG9yeS9uZXdzLzI0MTExMzk1L2FtZ24tdnMtbGx5LXdoaWNoLWJpb3RlY2gtc3RvY2staXMtYS1iZXR0ZXItYnV5LXJpZ2h0LW5vd9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTJNVmg2YlU0d1JFVndSME5ZVFJDNkFSaVBBaWdCTWdB=-w200-h112-p-df", "media": "Barchart", "site": null, "reporter": "Sushree Mohanty", "sentiment": "negative"}, {"title": "The Zacks Analyst Blog Highlights NVIDIA, Visa, Amgen, Chubb and PACCAR", "desc": null, "date": "29/02/2024", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy96YWNrcy1hbmFseXN0LWJsb2ctaGlnaGxpZ2h0cy1udmlkaWEtMTQxNTAwMTcxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHljMWgwWDNoc1VqSktWRE5mVFJDeUFSaWJBaWdCTWdZQjFZNkZSZ1U=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen analysts boost target price on obesity drug data outlook", "desc": null, "date": "03/01/2024", "link": "news.google.com/articles/CBMihQFodHRwczovL3d3dy5wcm9hY3RpdmVpbnZlc3RvcnMuY29tL2NvbXBhbmllcy9uZXdzLzEwMzc0MjMvYW1nZW4tYW5hbHlzdHMtYm9vc3QtdGFyZ2V0LXByaWNlLW9uLW9iZXNpdHktZHJ1Zy1kYXRhLW91dGxvb2stMTAzNzQyMy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJVMVpTV0ZreVdWaFlXbkJzVFJDWkFSaktBaWdCTWdZQkU0cE93UVE=-w200-h112-p-df", "media": "Proactive Investors USA", "site": null, "reporter": "Angela Harmantas", "sentiment": "negative"}, {"title": "Amgen: Q4 Earnings Snapshot", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiNGh0dHBzOi8vcXouY29tL2FtZ2VuLXE0LWVhcm5pbmdzLXNuYXBzaG90LTE4NTEyMzE4NDHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNOMVJFZDFaV1VUUkplVmx4VFJDcEFSaXJBaWdCTWdB=-w200-h112-p-df", "media": "Quartz", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Biotech Stocks to Buy on the Dip: March 2024", "desc": null, "date": "27/03/2024", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMy8zLWJpb3RlY2gtc3RvY2tzLXRvLWJ1eS1vbi10aGUtZGlwLW1hcmNoLTIwMjQv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVZaVGxCUWxSMUxXZFdhWEZFVFJDb0FSaXNBaWdCTWdNQlV3dw=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Ian Cooper", "sentiment": "negative"}, {"title": "Here's Why We're Wary Of Buying Amgen's (NASDAQ:AMGN) For Its Upcoming Dividend", "desc": null, "date": "10/02/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vdWsuZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktd2VyZS13YXJ5LWJ1eWluZy0xMjU1Mzg1NzAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU1NekU0Y0dnMVpYRmFhbXhJVFJDd0FSaWVBaWdCTWdhWkVwUlJxUWM=-w200-h112-p-df", "media": "Yahoo Finance UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "PBYI vs. AMGN: Which Stock Should Value Investors Buy Now?", "desc": null, "date": "09/02/2024", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyMjQyNTUvcGJ5aS12cy1hbWduLXdoaWNoLXN0b2NrLXNob3VsZC12YWx1ZS1pbnZlc3RvcnMtYnV5LW5vd9IBZGh0dHBzOi8vd3d3LnphY2tzLmNvbS9hbXAvc3RvY2svbmV3cy8yMjI0MjU1L3BieWktdnMtYW1nbi13aGljaC1zdG9jay1zaG91bGQtdmFsdWUtaW52ZXN0b3JzLWJ1eS1ub3c?hl=en-US&gl=US&ceid=US%3Aen", "img": null, "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Top Research Reports for Novartis, Amgen & Palo Alto Networks", "desc": null, "date": "24/01/2024", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90b3AtcmVzZWFyY2gtcmVwb3J0cy1ub3ZhcnRpcy1hbWdlbi0xOTE1MDA1NDkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9YMEpFWm1Wd1ZqVjVha2s0VFJDM0FSaVRBaWdCTWdZQmNJNExNZ2M=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Sheraz Mian", "sentiment": "positive"}, {"title": "Investors' Focus Around Amgen's Obesity Drug Data Shadows Better Than Expected Q4 Earnings", "desc": null, "date": "07/02/2024", "link": "news.google.com/articles/CBMilAFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9pbnZlc3RvcnMtZm9jdXMtYXJvdW5kLWFtZ2VuLXMtb2Jlc2l0eS1kcnVnLWRhdGEtc2hhZG93cy1iZXR0ZXItdGhhbi1leHBlY3RlZC1xNC1lYXJuaW5ncy0xMDMzMDQyNjIw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9PVXRCT1ZoNGJUSmFRMm93VFJEQ0FSaURBaWdCTWdZWmM0NXNNUVk=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields", "desc": null, "date": "13/03/2024", "link": "news.google.com/articles/CBMinQFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy93YWxsLXN0cmVldC1zLW1vc3QtYWNjdXJhdGUtYW5hbHlzdHMtdmlld3Mtb24tMy1oZWFsdGgtY2FyZS1zdG9ja3MtZGVsaXZlcmluZy1oaWdoLWRpdmlkZW5kLXlpZWxkcy0xMDMzMTU5MTk50gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdWRU5oUTNWRVdtUTVXR1JPVFJEQ0FSaURBaWdCTWdZQmdvd0ROUVk=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "U.S. Senator Tommy Tuberville Just Reported a Sale of $AMGN stock", "desc": null, "date": "15/02/2024", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmJhcmNoYXJ0LmNvbS9zdG9yeS9uZXdzLzI0MTExNDAyL3VzLXNlbmF0b3ItdG9tbXktdHViZXJ2aWxsZS1qdXN0LXJlcG9ydGVkLWEtc2FsZS1vZi1hbWduLXN0b2Nr0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJVR2s1ZFZWbVlTMUdNbFI0VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Barchart", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. (NASDAQ:AMGN) Q4 2023 Earnings Call Transcript", "desc": null, "date": "07/02/2024", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvYW1nZW4taW5jLW5hc2RhcWFtZ24tcTQtMjAyMy1lYXJuaW5ncy1jYWxsLXRyYW5zY3JpcHQtMTI1NDkyNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZTV0ZKWDNCVlNuQlBWRzlzVFJDb0FSaXNBaWdCTWdhaE1vWUxtZ2s=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": "Insider Monkey", "sentiment": "negative"}, {"title": "Noteworthy ETF Outflows: XLV, DHR, PFE, AMGN", "desc": null, "date": "26/02/2024", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvbm90ZXdvcnRoeS1ldGYtb3V0Zmxvd3M6LXhsdi1kaHItcGZlLWFtZ27SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTNUR3gxVjNKaVVuRk1ObmhxVFJDM0FSaVRBaWdCTWdNSkF3QQ=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Options Trading: A Deep Dive into Market Sentiment - Amgen (NASDAQ:AMGN)", "desc": null, "date": "28/03/2024", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9pbnNpZ2h0cy9vcHRpb25zLzI0LzAzLzM3OTg4MTE0L2FtZ2VuLW9wdGlvbnMtdHJhZGluZy1hLWRlZXAtZGl2ZS1pbnRvLW1hcmtldC1zZW50aW1lbnTSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzc5ODgxMTQ?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVYMk5DUzNkbWVEVkZVamhoVFJDM0FSaVRBaWdCTWdZQjVZUW5TZ1E=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says - Amgen", "desc": null, "date": "28/03/2024", "link": "news.google.com/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW5hbHlzdC1yYXRpbmdzL2FuYWx5c3QtY29sb3IvMjQvMDMvMzc5OTE5OTUvYW1nZW5zLWRpdmVyc2lmaWVkLXBvcnRmb2xpby10by1kcml2ZS1sb25nLXRlcm0tZ3Jvd3RoLXRob3VnaC11bmNlcnRhaW50aWVzLWxvb20tYW7SAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzc5OTE5OTU?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXdjbVF0VlZKRkxYZHRORXQwVFJDM0FSaVRBaWdCTWdrQkVJZ2x4cVRBOXdB=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Vandana Singh", "sentiment": "positive"}, {"title": "Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List Apple Sinks After Wall Street Titan ...", "desc": null, "date": "01/03/2024", "link": "news.google.com/articles/CBMimAFodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW5hbHlzdC1yYXRpbmdzL2FuYWx5c3QtY29sb3IvMjQvMDMvMzc0MjM4NzcvYXBwbGUtc2lua3MtYWZ0ZXItd2FsbC1zdHJlZXQtdGl0YW4tcHVsbHMtbWFnbmlmaWNlbnQtNy1zdG9jay1mcm9tLWNvbnZpY3Rpb24tbGlzdNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlNMW90UTFaT2FWY3dRVzlZVFJDM0FSaVRBaWdCTWdhQkVZWnBNUVk=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Chris Katje", "sentiment": "negative"}, {"title": "Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs", "desc": null, "date": "25/01/2024", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMS9zdG9ja3MtdG8td2F0Y2gtMy1jb21wYW5pZXMtd29ya2luZy1vbi1uZXh0LWdlbi13ZWlnaHQtbG9zcy1kcnVncy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhVRTV1ZVROalgyeFJaM05FVFJDb0FSaXNBaWdCTWdZbEJZak9KUVU=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Larry Ramer", "sentiment": "negative"}, {"title": "Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units - Amgen (NASDAQ:", "desc": null, "date": "16/01/2024", "link": "news.google.com/articles/CBMijwFodHRwczovL3d3dy5iZW56aW5nYS5jb20vbWFya2V0cy9lcXVpdGllcy8yNC8wMS8zNjY1Mzc4Ni9jYXRoaWUtd29vZHMtYXJrLWludmVzdC1saXF1aWRhdGVzLTE1LThtLXdvcnRoLW9mLXByb3NoYXJlcy1iaXRjb2luLXN0cmF0ZWd5LWV0Zi11bml0c9IBLWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hbXAvY29udGVudC8zNjY1Mzc4Ng?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUVaVGRCVFdReFRWcGlPVEJNVFJDM0FSaVRBaWdCTWdZWmVJeHByZ1k=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "5 Most Profitable Biotech Stocks To Invest In", "desc": null, "date": "14/03/2024", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvNS1tb3N0LXByb2ZpdGFibGUtYmlvdGVjaC1zdG9ja3MtdG8taW52ZXN0LWluLTEyNzMzOTMv0gFfaHR0cHM6Ly93d3cuaW5zaWRlcm1vbmtleS5jb20vYmxvZy81LW1vc3QtcHJvZml0YWJsZS1iaW90ZWNoLXN0b2Nrcy10by1pbnZlc3QtaW4tMTI3MzM5My8_YW1wPTE?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtSalpYVVhaR2NsQkdXaTFKVFJDb0FSaXNBaWdCTWdheEFZeTJBQTA=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": "Ramish Cheema", "sentiment": "positive"}]